GO	[-7.27 -0.58]	[-0.58 -0.26]	[-0.26 -0.14]	[-0.14 -0.04]	[-0.04 0.00]	[0.00 0.00]	[0.00 0.09]	[0.09 0.22]	[0.22 0.46]	[0.46 0.96]	[0.96 8.92]
SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM	-5.456	-0.543	8.532	10.783	-0.409	-5.456	1.700	0.530	-1.424	-5.456	-5.439
MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN	-5.112	0.353	3.895	8.280	0.261	-7.361	3.895	0.901	-0.761	-6.085	-5.094
PUJANA_XPRSS_INT_NETWORK PUJANA_XPRSS_INT_NETWORK	-6.985	1.507	3.594	3.594	-0.366	-6.985	2.295	3.244	-0.486	-4.779	-5.713
BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES	-1.963	-1.363	4.503	20.258	-0.935	-2.862	-0.935	-1.963	-1.963	-1.963	-1.357
BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP	-7.863	-0.596	3.701	5.204	0.342	-7.863	2.731	1.661	0.706	-2.464	-4.717
SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP	-6.401	-1.011	2.199	3.528	-1.276	-5.183	0.974	1.914	5.588	-1.011	-6.383
ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER	-5.817	-1.274	0.536	1.074	-0.996	-5.817	1.813	6.084	5.603	-1.608	-3.747
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17	-6.322	0.799	2.956	3.975	-0.525	-5.335	4.730	0.968	-0.402	-1.925	-5.316
FUJII_YBX1_TARGETS_DN FUJII_YBX1_TARGETS_DN	-4.876	1.792	5.388	1.792	-1.815	-6.718	1.343	2.887	0.405	-1.508	-4.857
CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN	-4.203	-0.399	5.332	3.826	-0.517	-8.072	3.160	1.124	-0.517	-1.260	-3.576
NOUZOVA_TRETINOIN_AND_H4_ACETYLATION NOUZOVA_TRETINOIN_AND_H4_ACETYLATION	-4.522	-0.396	1.379	3.622	-1.926	-5.692	5.815	2.536	0.320	-1.926	-2.949
PUJANA_BRCA_CENTERED_NETWORK PUJANA_BRCA_CENTERED_NETWORK	-4.900	1.695	3.050	2.326	0.413	-4.900	1.163	1.998	-0.443	-2.982	-4.886
SCHUHMACHER_MYC_TARGETS_UP SCHUHMACHER_MYC_TARGETS_UP	-2.363	0.724	10.570	4.109	-1.225	-3.319	0.520	-0.596	-1.707	-2.363	-2.355
DANG_MYC_TARGETS_UP DANG_MYC_TARGETS_UP	-3.404	0.533	5.352	7.959	-0.610	-4.251	1.583	-1.369	-1.369	-0.813	-3.391
RAMALHO_STEMNESS_UP RAMALHO_STEMNESS_UP	-4.236	-1.860	1.738	6.108	-0.408	-6.797	5.686	0.622	-0.672	-0.844	-1.269
KONDO_PROSTATE_CANCER_WITH_H3K27ME3 KONDO_PROSTATE_CANCER_WITH_H3K27ME3	0.781	-1.028	-3.592	-4.911	3.160	6.169	-1.260	-3.061	-1.028	-0.399	4.204
LEE_LIVER_CANCER_SURVIVAL_DN LEE_LIVER_CANCER_SURVIVAL_DN	-5.186	-0.621	2.495	8.635	-0.791	-3.710	2.209	1.045	-1.508	-0.791	-2.191
BENPORATH_PROLIFERATION BENPORATH_PROLIFERATION	-3.326	-0.904	2.744	2.420	-0.697	-6.151	1.568	1.568	3.087	-1.452	-4.034
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13	-3.102	-0.354	5.416	1.971	0.721	-6.125	1.971	1.971	-1.211	-1.211	-4.333
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN	-2.256	0.322	4.048	4.048	-1.760	-4.775	1.801	0.610	0.452	-1.034	-4.762
CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP	-1.431	-0.921	4.191	10.178	0.435	-2.239	-0.921	-0.578	-2.239	-1.431	-1.426
JISON_SICKLE_CELL_DISEASE_DN JISON_SICKLE_CELL_DISEASE_DN	-2.021	0.468	4.149	7.538	-0.335	-5.484	0.593	0.896	-1.681	-2.411	-2.008
DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER	-4.151	-1.355	2.071	4.119	-0.733	-4.151	3.659	1.164	0.249	-0.733	-3.097
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP	-1.615	0.783	-0.867	-2.333	-5.372	-4.560	0.293	0.502	1.797	2.613	6.381
GOLDRATH_HOMEOSTATIC_PROLIFERATION GOLDRATH_HOMEOSTATIC_PROLIFERATION	-3.326	0.433	3.829	0.568	0.568	-4.949	4.643	0.725	0.568	-2.728	-4.034
KARLSSON_TGFB1_TARGETS_UP KARLSSON_TGFB1_TARGETS_UP	-3.157	0.486	6.384	6.384	-1.985	-3.982	0.353	0.353	-1.558	-0.694	-1.201
MOOTHA_VOXPHOS MOOTHA_VOXPHOS	-1.420	0.576	3.140	4.080	0.782	-3.610	2.712	-0.731	-3.610	-1.933	-2.612
MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN	-3.153	0.824	3.408	5.583	0.824	-3.153	0.598	-0.775	-0.775	-3.153	-2.209
FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN	-3.468	-1.447	-0.473	0.334	-1.747	-4.770	0.555	5.557	6.866	0.436	-0.954
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN	-1.804	-0.319	2.787	6.369	-3.196	-4.595	0.805	1.901	0.384	-2.197	-1.458
FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP	-5.183	0.791	4.301	3.168	-0.459	-4.267	1.403	0.974	-1.011	-0.608	-2.901
WHITFIELD_CELL_CYCLE_G2 WHITFIELD_CELL_CYCLE_G2	-4.039	-1.045	0.434	0.706	-0.498	-7.027	0.327	2.261	5.970	0.706	-1.037
GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP	-5.409	-0.318	2.577	0.620	-2.359	-6.401	0.932	1.114	3.532	-0.701	0.626
WANG_CLIM2_TARGETS_DN WANG_CLIM2_TARGETS_DN	-5.298	-0.513	-0.293	2.685	-0.513	-5.298	2.114	4.783	0.987	-0.836	-1.561
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP	-3.039	-0.378	-0.856	-1.360	-2.065	-2.065	-0.856	-1.360	4.901	2.994	5.806
WELCSH_BRCA1_TARGETS_DN WELCSH_BRCA1_TARGETS_DN	-2.034	2.068	4.210	2.703	0.522	-4.677	0.391	1.272	-2.515	-2.515	-2.024
OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP	-4.900	-1.099	1.163	2.676	1.163	-4.900	2.676	1.417	0.291	-1.099	-1.834
FISCHER_G1_S_CELL_CYCLE FISCHER_G1_S_CELL_CYCLE	-3.779	4.629	4.261	2.092	-0.919	-3.779	1.393	-1.130	-0.919	-1.654	-0.732
ZHENG_FOXP3_TARGETS_IN_THYMUS_UP ZHENG_FOXP3_TARGETS_IN_THYMUS_UP	-3.177	0.358	0.358	2.151	-0.889	-8.239	1.660	1.898	1.898	0.583	-2.278
VERHAAK_AML_WITH_NPM1_MUTATED_UP VERHAAK_AML_WITH_NPM1_MUTATED_UP	-0.432	0.606	-1.367	-1.114	-1.367	-3.345	-2.385	-1.367	1.094	2.842	9.147
GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	-2.359	1.114	2.291	1.533	0.491	-6.401	2.291	-0.422	0.932	-0.422	-5.390
MOHANKUMAR_HOXA1_TARGETS_DN MOHANKUMAR_HOXA1_TARGETS_DN	-0.405	-0.301	-5.888	-1.362	0.402	0.402	-1.362	-0.533	-1.669	2.448	8.714
WINNEPENNINCKX_MELANOMA_METASTASIS_UP WINNEPENNINCKX_MELANOMA_METASTASIS_UP	-3.165	0.660	1.207	0.660	0.292	-5.496	1.207	2.827	2.827	-2.170	-3.151
GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN	-1.241	1.330	5.714	4.856	-0.347	-3.936	0.468	-0.782	-1.877	-0.992	-2.731
ALCALAY_AML_BY_NPM1_LOCALIZATION_DN ALCALAY_AML_BY_NPM1_LOCALIZATION_DN	-2.385	2.258	0.606	1.094	-2.385	-7.737	0.606	1.094	3.489	-0.560	-0.890
MISSIAGLIA_REGULATED_BY_METHYLATION_DN MISSIAGLIA_REGULATED_BY_METHYLATION_DN	-3.122	0.500	2.853	3.633	-1.186	-5.067	0.500	2.161	0.364	-0.905	-2.466
ZHANG_RESPONSE_TO_CANTHARIDIN_DN ZHANG_RESPONSE_TO_CANTHARIDIN_DN	-1.302	1.096	7.276	3.079	-0.885	-2.779	0.238	-0.586	-0.885	-1.302	-2.771
PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP	-3.061	0.396	3.486	5.332	-0.659	-4.203	0.944	0.944	0.301	-1.528	-3.046
LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP	-2.333	-0.536	0.783	4.295	-0.412	-6.362	2.918	0.783	0.950	-0.536	-3.269
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN	-0.829	0.301	-1.028	-0.829	-1.837	-5.746	-1.028	0.507	0.396	3.826	7.090
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP	-2.740	0.367	3.856	5.273	-0.703	-4.609	1.363	-0.508	-0.508	-0.950	-1.641
HOLLERN_SQUAMOUS_BREAST_TUMOR HOLLERN_SQUAMOUS_BREAST_TUMOR	-0.533	-1.100	-2.922	-2.922	1.639	6.689	-1.669	-2.440	-0.301	0.818	2.770
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP	-2.606	-0.608	-0.354	0.884	-1.211	-5.149	0.451	5.845	4.217	-1.211	-0.602
KAAB_FAILED_HEART_ATRIUM_DN KAAB_FAILED_HEART_ATRIUM_DN	-2.698	-2.200	1.864	2.786	1.126	-6.109	0.923	2.151	-0.275	-0.381	-1.771
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14	-3.904	0.359	7.294	1.963	0.628	-3.193	-0.834	0.257	0.795	-0.834	-2.594
CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP	-3.977	-0.667	0.943	1.897	-1.113	-6.067	1.626	1.377	2.187	0.597	-1.746
MIKKELSEN_IPS_WITH_HCP_H3K27ME3 MIKKELSEN_IPS_WITH_HCP_H3K27ME3	2.658	-1.434	-1.434	-0.569	0.334	5.925	-1.888	-3.220	-1.888	-0.569	2.671
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN	-1.990	-0.451	4.862	3.588	-0.451	-1.990	1.565	-0.451	-0.755	-1.990	-1.984
HUANG_GATA2_TARGETS_UP HUANG_GATA2_TARGETS_UP	-2.821	-1.520	-1.883	-0.424	0.526	-6.276	0.292	1.738	2.621	1.738	2.026
TAKAO_RESPONSE_TO_UVB_RADIATION_UP TAKAO_RESPONSE_TO_UVB_RADIATION_UP	-2.621	-1.933	1.604	4.080	0.267	-1.933	1.604	3.140	-1.029	-1.420	-2.612
HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP	-4.194	-0.436	0.659	0.513	0.283	-4.194	2.271	2.911	2.911	-0.975	-2.839
SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN	1.612	-1.118	-1.118	-2.468	-1.382	3.033	-1.382	-2.952	-1.118	2.714	4.496
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP	0.770	-0.767	-3.901	-1.852	-0.594	0.770	-2.715	-1.221	0.480	1.840	7.720
PODAR_RESPONSE_TO_ADAPHOSTIN_UP PODAR_RESPONSE_TO_ADAPHOSTIN_UP	-2.759	-1.173	0.310	-0.402	-1.173	-4.988	-0.712	1.800	5.924	2.382	-0.289
WHITEFORD_PEDIATRIC_CANCER_MARKERS WHITEFORD_PEDIATRIC_CANCER_MARKERS	-2.947	0.959	2.037	0.755	-0.810	-2.947	1.447	0.959	3.102	-2.319	-3.740
XIE_LT_HSC_S1PR3_OE_UP XIE_LT_HSC_S1PR3_OE_UP	0.302	-1.202	-1.202	-1.202	-1.202	-1.202	-0.300	-0.610	-1.202	3.824	6.342
KAUFFMANN_MELANOMA_RELAPSE_UP KAUFFMANN_MELANOMA_RELAPSE_UP	-2.529	2.540	3.023	2.540	-1.122	-2.529	-0.287	0.498	0.315	-1.677	-2.522
UDAYAKUMAR_MED1_TARGETS_UP UDAYAKUMAR_MED1_TARGETS_UP	-2.365	-0.384	1.666	4.947	-0.384	-4.483	0.763	1.948	0.451	-2.365	-1.889
EPPERT_PROGENITOR EPPERT_PROGENITOR	-2.425	0.310	3.570	2.833	-0.959	-5.734	1.880	0.727	-0.407	-1.559	-0.729
DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN	-0.598	-0.430	0.959	-0.598	-1.815	-3.752	-1.408	-2.319	0.959	6.896	2.049
MIKKELSEN_IPS_ICP_WITH_H3K27ME3 MIKKELSEN_IPS_ICP_WITH_H3K27ME3	1.601	-0.600	-1.466	-2.280	-0.949	2.973	-2.280	-2.280	-0.600	1.232	3.524
KAUFFMANN_DNA_REPLICATION_GENES KAUFFMANN_DNA_REPLICATION_GENES	-1.781	2.786	4.283	2.459	-0.275	-4.013	-0.682	0.582	-0.381	-2.200	-2.189
WELCSH_BRCA1_TARGETS_UP WELCSH_BRCA1_TARGETS_UP	-5.971	-1.130	0.842	0.442	-0.351	-4.403	2.356	3.567	1.009	0.442	-0.732
MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3 MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	0.330	-1.642	0.330	-1.093	-0.715	-1.093	-0.715	-1.642	-1.093	0.756	11.657
WHITFIELD_CELL_CYCLE_G2_M WHITFIELD_CELL_CYCLE_G2_M	-3.717	-1.335	0.463	0.358	-0.562	-5.053	0.270	4.729	3.652	0.463	-0.432
LI_DCP2_BOUND_MRNA LI_DCP2_BOUND_MRNA	-2.658	0.557	3.529	2.263	0.390	-3.652	0.256	0.390	0.995	-1.053	-3.641
SERVITJA_ISLET_HNF1A_TARGETS_UP SERVITJA_ISLET_HNF1A_TARGETS_UP	0.560	-0.375	-2.833	-2.358	-1.045	0.706	-1.951	-2.358	0.706	4.292	4.712
RICKMAN_HEAD_AND_NECK_CANCER_C RICKMAN_HEAD_AND_NECK_CANCER_C	2.076	-0.582	0.439	-1.787	0.593	6.985	-3.714	-2.288	-1.787	-0.291	0.443
CROONQUIST_IL6_DEPRIVATION_DN CROONQUIST_IL6_DEPRIVATION_DN	-3.943	0.441	1.942	1.615	-0.897	-3.943	1.052	1.318	1.615	-0.897	-2.189
RICKMAN_HEAD_AND_NECK_CANCER_E RICKMAN_HEAD_AND_NECK_CANCER_E	1.023	-1.933	-3.610	-1.029	0.267	6.274	-1.420	-1.933	0.267	1.023	1.030
SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP	-1.803	-0.289	4.926	2.523	-0.289	-2.473	0.657	0.883	-0.442	-3.444	-1.796
PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	-2.929	-0.384	-0.703	2.577	-2.365	-4.483	0.330	1.666	3.289	1.169	-0.697
TIEN_INTESTINE_PROBIOTICS_6HR_UP TIEN_INTESTINE_PROBIOTICS_6HR_UP	-2.239	0.435	1.274	8.479	-0.578	-0.921	0.258	-0.921	0.258	-2.239	-1.426
SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP	-0.399	0.309	0.309	-1.124	-1.731	-5.417	-1.731	0.309	1.046	1.729	6.134
LEE_EARLY_T_LYMPHOCYTE_UP LEE_EARLY_T_LYMPHOCYTE_UP	-1.595	-1.214	0.542	-0.668	-1.595	-2.071	0.392	2.031	8.255	0.392	-2.061
DITTMER_PTHLH_TARGETS_UP DITTMER_PTHLH_TARGETS_UP	-3.599	-1.704	0.837	2.199	-0.537	-4.692	1.057	2.920	-0.738	1.057	-0.377
TIEN_INTESTINE_PROBIOTICS_6HR_DN TIEN_INTESTINE_PROBIOTICS_6HR_DN	-4.853	-0.385	-0.510	2.520	-0.662	-5.810	0.547	1.952	1.695	0.547	0.322
XIE_ST_HSC_S1PR3_OE_UP XIE_ST_HSC_S1PR3_OE_UP	0.896	-0.728	-0.728	-0.442	-1.681	-1.681	-1.681	-1.681	0.360	1.074	10.127
MALONEY_RESPONSE_TO_17AAG_DN MALONEY_RESPONSE_TO_17AAG_DN	-1.612	-0.355	2.046	1.680	0.253	-3.194	4.353	0.396	-0.797	-0.797	-3.185
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR	-2.510	0.451	3.807	0.856	-0.672	-2.510	0.636	2.468	0.451	-1.336	-3.475
SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP	-1.948	-0.242	3.688	2.561	0.370	-1.948	1.225	0.370	-1.948	-1.191	-1.943
PECE_MAMMARY_STEM_CELL_UP PECE_MAMMARY_STEM_CELL_UP	-2.994	-0.292	3.570	5.743	0.727	-2.994	-0.292	-0.407	-0.553	-1.559	-0.952
IRITANI_MAD1_TARGETS_DN IRITANI_MAD1_TARGETS_DN	-1.907	1.677	3.791	3.193	-0.228	-1.907	-0.228	-0.702	-1.158	-1.158	-1.901
ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR	-2.573	-0.273	2.045	0.331	-0.727	-3.227	0.331	2.368	3.080	0.331	-4.045
WIERENGA_STAT5A_TARGETS_DN WIERENGA_STAT5A_TARGETS_DN	-2.167	0.405	-1.011	-1.241	-1.241	-4.170	0.649	-0.389	0.962	2.042	6.259
KONG_E2F3_TARGETS KONG_E2F3_TARGETS	-1.709	-0.476	-0.476	0.997	-0.324	-4.026	0.412	4.331	2.577	-0.324	-2.984
ELVIDGE_HYPOXIA_DN ELVIDGE_HYPOXIA_DN	-2.728	-0.528	1.832	1.832	-0.284	-6.151	1.568	1.325	0.568	-0.284	-1.797
LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q	-2.288	1.218	0.775	1.479	-0.582	-4.817	1.479	3.559	-0.792	-1.055	-1.375
GROSS_HYPOXIA_VIA_HIF1A_UP GROSS_HYPOXIA_VIA_HIF1A_UP	-3.194	0.253	6.089	1.055	-0.355	-3.194	0.798	0.253	0.396	-1.144	-1.139
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN	-2.385	0.479	1.741	0.751	-1.114	-2.831	0.751	2.258	3.489	-1.367	-3.330
WIERENGA_STAT5A_TARGETS_GROUP1 WIERENGA_STAT5A_TARGETS_GROUP1	0.578	-0.292	-0.566	-1.003	-3.298	-3.298	-0.761	-0.412	-0.292	4.185	4.647
ALCALAY_AML_BY_NPM1_LOCALIZATION_UP ALCALAY_AML_BY_NPM1_LOCALIZATION_UP	-1.274	-0.580	-0.996	-0.767	-1.608	-3.060	-0.767	-0.430	1.545	3.097	6.109
BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP	-2.197	-1.397	0.272	6.316	-0.893	-2.197	0.980	0.272	1.706	-0.893	-0.888
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN	-1.424	-0.327	2.064	3.283	0.617	-7.278	0.485	0.617	0.372	-0.570	-1.414
KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP	-0.373	-0.373	-2.336	-2.336	-0.903	1.194	-1.872	-0.687	-0.373	1.698	7.542
KRIEG_KDM3A_TARGETS_NOT_HYPOXIA KRIEG_KDM3A_TARGETS_NOT_HYPOXIA	-1.633	0.706	3.282	1.635	-0.904	-5.934	1.870	-0.343	1.028	-0.904	-1.621
KANG_DOXORUBICIN_RESISTANCE_UP KANG_DOXORUBICIN_RESISTANCE_UP	-2.239	-0.921	0.664	0.258	-0.578	-2.239	0.664	2.076	4.817	-0.578	-2.233
FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP	-3.867	0.374	2.437	3.422	-0.581	-3.228	0.787	1.162	0.630	-0.957	-2.212
GAVIN_FOXP3_TARGETS_CLUSTER_P6 GAVIN_FOXP3_TARGETS_CLUSTER_P6	-2.770	-0.572	-0.391	0.693	-1.534	-2.770	0.504	3.794	4.279	-1.127	-0.387
BASSO_B_LYMPHOCYTE_NETWORK BASSO_B_LYMPHOCYTE_NETWORK	-2.667	0.457	5.661	2.187	-1.113	-3.977	-0.503	0.759	0.457	-0.869	-0.661
WHITFIELD_CELL_CYCLE_M_G1 WHITFIELD_CELL_CYCLE_M_G1	-2.043	-1.254	1.746	3.878	-0.273	-3.227	2.713	0.458	0.458	-1.254	-2.033
ZHAN_MULTIPLE_MYELOMA_PR_UP ZHAN_MULTIPLE_MYELOMA_PR_UP	-1.907	-1.158	0.920	0.389	-1.907	-0.702	-0.228	2.640	4.433	-0.702	-1.901
WHITFIELD_CELL_CYCLE_S WHITFIELD_CELL_CYCLE_S	-2.228	1.103	0.903	3.829	0.568	-4.049	1.325	0.433	-0.284	-0.904	-3.312
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN	-2.603	0.290	-0.451	3.240	-1.167	-3.372	0.976	1.789	1.789	0.290	-2.592
PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN	-3.977	-0.869	1.897	1.150	-0.503	-3.259	3.934	0.338	1.377	-0.667	-1.105
HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP	-3.072	0.261	1.085	2.566	1.085	-6.085	1.287	0.590	0.590	-0.595	-1.456
VILLANUEVA_LIVER_CANCER_KRT19_UP VILLANUEVA_LIVER_CANCER_KRT19_UP	-2.523	0.485	0.617	0.768	0.276	-4.246	0.768	3.991	1.559	-0.732	-2.997
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN	-0.402	0.421	-2.256	-2.759	-1.832	0.310	-0.921	-0.402	0.554	1.081	7.969
PUJANA_BREAST_CANCER_LIT_INT_NETWORK PUJANA_BREAST_CANCER_LIT_INT_NETWORK	-1.828	0.507	2.760	2.381	-1.029	-4.192	0.687	0.896	0.896	-1.381	-1.820
JAIN_NFKB_SIGNALING JAIN_NFKB_SIGNALING	-1.517	0.878	2.200	2.619	-0.488	-3.070	1.815	-0.314	-0.314	-1.064	-3.061
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP	-3.291	0.601	3.688	1.810	-0.992	-4.706	-0.347	0.754	1.118	0.260	-1.232
DAZARD_RESPONSE_TO_UV_SCC_DN DAZARD_RESPONSE_TO_UV_SCC_DN	-1.358	-0.774	0.610	0.795	-0.567	-4.775	2.820	1.510	2.456	-1.034	-1.751
STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP	-1.661	0.749	1.166	2.286	0.311	-5.275	0.432	0.432	1.679	-0.412	-3.286
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK	-1.384	-0.652	0.469	0.964	-0.258	-4.832	3.225	0.777	2.538	-0.652	-2.625
CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN	0.318	0.423	-0.510	-1.976	-3.419	-1.063	-1.321	-0.845	1.236	1.952	5.933
WHITFIELD_CELL_CYCLE_G1_S WHITFIELD_CELL_CYCLE_G1_S	-1.439	1.245	5.619	1.492	-0.486	-2.276	0.820	0.255	-0.486	-1.819	-2.819
IVANOVSKA_MIR106B_TARGETS IVANOVSKA_MIR106B_TARGETS	-2.658	-1.448	-0.351	0.557	-1.053	-3.652	3.529	2.656	0.759	0.390	-0.348
NAGASHIMA_NRG1_SIGNALING_UP NAGASHIMA_NRG1_SIGNALING_UP	-1.382	0.509	-0.545	0.392	-4.964	-4.177	0.801	0.801	0.801	1.861	2.142
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP	1.104	1.299	-0.528	-0.408	-3.090	-4.236	-1.860	-0.844	1.510	1.983	2.260
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN	-0.986	1.259	3.786	0.966	-1.424	-2.035	0.966	0.328	0.712	-2.945	-2.028
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN	-1.383	-1.055	-0.418	-0.582	-1.787	-3.714	-0.582	0.593	3.986	3.154	1.226
MORI_LARGE_PRE_BII_LYMPHOCYTE_UP MORI_LARGE_PRE_BII_LYMPHOCYTE_UP	-2.658	-0.751	1.264	0.759	0.256	-3.652	0.557	1.565	3.529	-1.448	-1.047
RHODES_UNDIFFERENTIATED_CANCER RHODES_UNDIFFERENTIATED_CANCER	-2.862	-0.252	2.065	0.357	-0.626	-2.862	0.357	2.484	2.065	-0.626	-1.956
BROWN_MYELOID_CELL_DEVELOPMENT_UP BROWN_MYELOID_CELL_DEVELOPMENT_UP	-1.556	-0.798	-1.901	-0.798	-0.798	-1.556	-0.475	-0.798	1.306	4.397	4.823
GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN	-1.855	0.846	1.132	2.673	0.405	-1.855	1.132	1.458	-1.271	-1.855	-2.729
JISON_SICKLE_CELL_DISEASE_UP JISON_SICKLE_CELL_DISEASE_UP	-1.901	-1.901	-0.392	-0.392	-0.836	-4.490	0.309	2.685	1.177	0.662	3.685
RHODES_CANCER_META_SIGNATURE RHODES_CANCER_META_SIGNATURE	-2.654	0.440	2.349	0.651	-0.810	-2.654	2.349	0.440	1.205	-1.211	-1.777
MORI_IMMATURE_B_LYMPHOCYTE_DN MORI_IMMATURE_B_LYMPHOCYTE_DN	-2.770	-0.572	0.914	0.914	-0.258	-3.776	-0.258	1.772	3.794	-0.812	-1.120
DAZARD_UV_RESPONSE_CLUSTER_G6 DAZARD_UV_RESPONSE_CLUSTER_G6	-1.706	-0.834	2.915	0.795	-0.478	-5.984	1.963	0.985	0.482	-0.350	-0.828
KASLER_HDAC7_TARGETS_1_UP KASLER_HDAC7_TARGETS_1_UP	-2.517	-0.371	1.610	0.425	-1.204	-5.634	0.543	2.659	2.102	-0.278	-0.479
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP	0.599	1.352	-1.048	-1.048	-3.595	-3.595	-0.636	-0.260	1.591	0.934	3.452
SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC	-1.540	0.576	4.582	1.789	0.762	-3.372	0.290	0.419	-0.451	-1.167	-2.592
SASAKI_ADULT_T_CELL_LEUKEMIA SASAKI_ADULT_T_CELL_LEUKEMIA	-2.804	-0.486	1.282	2.014	-1.027	-4.779	0.722	2.910	-0.269	0.722	-1.019
ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP	-0.301	1.402	1.726	1.726	-1.336	-3.485	1.726	0.451	-1.836	-0.301	-2.502
SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER	-0.228	-1.907	-0.228	-0.702	-0.702	-0.702	-1.907	0.389	0.389	-0.411	8.267
HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP	-0.647	0.519	7.583	-0.264	0.519	-1.999	-0.647	-0.647	-0.264	-0.264	-2.895
POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN	-1.824	-1.090	1.798	6.141	-0.650	-1.090	0.430	0.684	-1.090	-1.090	-0.647
JOHNSTONE_PARVB_TARGETS_2_UP JOHNSTONE_PARVB_TARGETS_2_UP	-1.731	-0.851	-0.652	0.964	-0.360	-6.025	0.964	0.612	2.872	1.404	-0.485
BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	1.336	-1.963	-1.363	-0.935	0.357	2.939	-1.363	-1.963	-1.363	2.065	1.689
MCBRYAN_PUBERTAL_BREAST_5_6WK_DN MCBRYAN_PUBERTAL_BREAST_5_6WK_DN	-3.439	1.298	0.677	0.273	1.298	-2.218	1.830	1.298	0.677	-1.084	-3.427
WOOD_EBV_EBNA1_TARGETS_UP WOOD_EBV_EBNA1_TARGETS_UP	-0.346	0.526	0.905	0.261	-4.567	-3.485	0.261	1.136	3.076	0.526	-0.924
PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP	-2.280	0.910	0.637	2.973	0.245	-2.280	0.416	1.232	0.416	-2.280	-1.461
IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR	-2.306	1.463	0.627	1.219	-0.671	-3.546	2.019	2.663	-0.363	-1.463	-1.454
KAMMINGA_EZH2_TARGETS KAMMINGA_EZH2_TARGETS	-1.699	0.285	1.997	1.997	-0.574	-1.699	1.129	-0.574	1.534	-1.699	-1.695
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP	0.376	-1.077	-1.077	-1.999	-1.477	-0.771	-1.477	1.856	3.463	3.463	-0.534
HOSHIDA_LIVER_CANCER_SUBCLASS_S2 HOSHIDA_LIVER_CANCER_SUBCLASS_S2	-1.787	0.593	0.983	0.775	0.983	-4.817	1.218	2.076	-0.291	-2.288	-0.786
CROONQUIST_NRAS_SIGNALING_DN CROONQUIST_NRAS_SIGNALING_DN	-2.903	-0.422	1.636	0.997	-0.647	-2.903	1.297	1.297	1.297	-0.422	-1.992
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS	-4.328	-0.473	1.522	0.660	-0.342	-3.475	1.522	1.796	1.044	-1.416	0.267
MIKKELSEN_IPS_LCP_WITH_H3K4ME3 MIKKELSEN_IPS_LCP_WITH_H3K4ME3	1.861	-0.704	-2.952	-1.382	-1.118	0.292	-1.118	-0.893	0.801	0.509	6.190
MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED	3.203	-0.326	-2.584	-1.005	0.806	1.644	-1.901	-2.584	-0.711	0.419	1.653
BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP	-1.081	-0.521	-0.676	-0.293	-0.861	-1.646	-0.676	-0.521	-0.521	0.835	9.882
SEIDEN_ONCOGENESIS_BY_MET SEIDEN_ONCOGENESIS_BY_MET	-1.999	-0.364	0.736	1.856	-0.771	-1.999	3.463	0.967	0.967	-1.999	-1.991
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP	1.065	0.451	-0.976	-0.608	-1.211	-5.149	-0.468	-0.976	1.971	0.577	3.869
ISSAEVA_MLL2_TARGETS ISSAEVA_MLL2_TARGETS	0.728	-1.677	-1.122	0.315	-1.677	0.315	-1.122	-0.287	-1.677	1.325	5.990
BOYLAN_MULTIPLE_MYELOMA_PCA1_UP BOYLAN_MULTIPLE_MYELOMA_PCA1_UP	0.594	0.594	-1.635	-0.744	-1.277	-0.744	-0.744	-1.277	-0.744	0.768	8.365
BROWN_MYELOID_CELL_DEVELOPMENT_DN BROWN_MYELOID_CELL_DEVELOPMENT_DN	-2.637	-0.292	5.087	1.166	1.410	-3.298	-0.761	0.311	-0.412	-0.292	-0.996
GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN	-2.696	0.967	4.432	0.246	-1.999	-2.696	0.539	0.376	1.231	-0.538	-0.534
JIANG_HYPOXIA_NORMAL JIANG_HYPOXIA_NORMAL	-0.919	-0.739	1.393	0.442	-1.654	-5.971	3.567	0.842	0.559	-0.264	0.346
GAVIN_FOXP3_TARGETS_CLUSTER_T7 GAVIN_FOXP3_TARGETS_CLUSTER_T7	-1.381	-0.752	5.030	0.507	-1.029	-3.145	0.359	2.028	0.687	-0.537	-1.374
WAKASUGI_HAVE_ZNF143_BINDING_SITES WAKASUGI_HAVE_ZNF143_BINDING_SITES	-1.431	2.076	3.602	1.652	-0.578	-2.239	0.258	-0.578	0.258	-1.431	-1.426
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP	-3.725	-0.751	-0.301	0.892	-0.418	-2.455	1.575	2.789	1.325	0.710	-1.970
NAGASHIMA_EGF_SIGNALING_UP NAGASHIMA_EGF_SIGNALING_UP	-1.006	0.845	-1.536	-0.645	-2.363	-2.363	-0.235	-0.235	1.151	2.339	2.349
ABRAMSON_INTERACT_WITH_AIRE ABRAMSON_INTERACT_WITH_AIRE	-1.090	0.998	4.677	1.370	0.684	-1.090	-0.650	-0.650	-0.373	-1.824	-1.819
MEBARKI_HCC_PROGENITOR_WNT_UP MEBARKI_HCC_PROGENITOR_WNT_UP	2.182	-0.551	-2.678	-0.873	-2.266	-1.906	-0.551	-0.326	0.892	2.454	2.759
WONG_PROTEASOME_GENE_MODULE WONG_PROTEASOME_GENE_MODULE	-1.294	-0.492	1.461	3.991	0.521	-2.073	1.461	-0.492	-0.492	-0.810	-2.067
ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP	-3.376	-2.021	-0.442	-0.442	-1.132	-1.681	0.468	0.896	1.714	1.270	3.812
ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION	-0.983	-1.635	-1.277	-0.744	-0.744	-0.552	-1.277	-0.552	0.967	3.820	4.712
WU_CELL_MIGRATION WU_CELL_MIGRATION	0.647	-1.062	-1.594	-1.062	-1.925	-0.525	-1.308	-0.402	0.799	1.584	6.446
OUILLETTE_CLL_13Q14_DELETION_UP OUILLETTE_CLL_13Q14_DELETION_UP	-0.523	-0.341	-2.217	1.087	0.265	-1.580	4.996	1.087	0.598	-2.217	-1.112
PYEON_HPV_POSITIVE_TUMORS_UP PYEON_HPV_POSITIVE_TUMORS_UP	-0.984	0.259	5.190	1.194	-0.714	-4.109	-0.506	0.384	0.540	0.259	-1.322
REICHERT_MITOSIS_LIN9_TARGETS REICHERT_MITOSIS_LIN9_TARGETS	-0.550	-0.550	-1.119	-0.550	-0.550	-1.119	-0.550	2.052	5.835	0.347	-1.116
SMITH_TERT_TARGETS_UP SMITH_TERT_TARGETS_UP	-3.226	-0.258	0.964	1.404	-0.851	-2.637	1.404	2.224	1.173	-0.490	-2.134
MILI_PSEUDOPODIA_CHEMOTAXIS_UP MILI_PSEUDOPODIA_CHEMOTAXIS_UP	-2.584	0.419	0.278	2.768	-0.489	-3.568	1.331	1.644	0.278	-0.326	-1.385
MORI_PRE_BI_LYMPHOCYTE_UP MORI_PRE_BI_LYMPHOCYTE_UP	-1.739	-1.253	1.856	-0.412	-0.614	-2.400	-0.266	2.230	3.071	-1.739	0.505
DER_IFN_BETA_RESPONSE_UP DER_IFN_BETA_RESPONSE_UP	-2.466	1.080	-0.270	2.658	-0.569	-3.220	1.080	0.334	1.340	0.334	-2.457
YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP	-1.397	-0.893	3.135	4.932	-0.332	-0.893	-0.332	-1.397	0.455	-1.397	-0.553
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN	-1.477	1.528	1.528	4.432	-1.077	-1.999	-0.538	0.736	-0.364	-0.771	-1.991
TIEN_INTESTINE_PROBIOTICS_2HR_UP TIEN_INTESTINE_PROBIOTICS_2HR_UP	-1.243	-0.320	0.283	8.025	-0.640	-0.320	-0.640	-0.640	0.539	-0.640	-1.240
TIEN_INTESTINE_PROBIOTICS_2HR_DN TIEN_INTESTINE_PROBIOTICS_2HR_DN	-1.999	-0.538	-1.477	1.231	0.246	-3.693	0.376	2.602	1.528	0.967	-0.766
REN_BOUND_BY_E2F REN_BOUND_BY_E2F	-0.762	3.461	1.284	1.284	-0.489	-1.152	0.301	-0.301	0.478	-2.571	-2.564
CHANDRAN_METASTASIS_TOP50_UP CHANDRAN_METASTASIS_TOP50_UP	-1.616	-0.525	1.656	1.656	0.555	-1.616	0.858	-0.525	1.656	-1.616	-1.612
KARLSSON_TGFB1_TARGETS_DN KARLSSON_TGFB1_TARGETS_DN	-3.623	0.293	-0.844	0.926	-0.528	-4.236	0.622	2.813	0.766	1.299	0.297
WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN	-0.468	-1.393	0.333	0.547	-2.787	-4.436	0.333	2.602	2.062	0.826	0.553
BURTON_ADIPOGENESIS_3 BURTON_ADIPOGENESIS_3	-2.432	-0.553	1.108	1.108	-0.385	-3.183	0.667	1.665	1.986	-0.260	-2.423
RUIZ_TNC_TARGETS_DN RUIZ_TNC_TARGETS_DN	-4.754	0.495	2.960	1.459	-0.623	-2.576	1.222	0.265	-0.465	0.369	-0.461
PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	-1.027	0.574	0.445	3.244	-1.027	-4.004	-0.486	2.014	1.507	-0.634	-1.568
ALONSO_METASTASIS_UP ALONSO_METASTASIS_UP	-3.061	-0.829	1.124	1.765	-0.399	-4.911	1.321	1.535	0.396	0.301	-0.297
VILIMAS_NOTCH1_TARGETS_UP VILIMAS_NOTCH1_TARGETS_UP	-0.513	-0.513	-0.513	-2.114	-0.513	-0.837	-0.837	-0.513	-0.301	1.818	6.621
SWEET_KRAS_TARGETS_UP SWEET_KRAS_TARGETS_UP	0.313	-0.289	-0.652	0.313	-2.473	-2.473	-0.934	0.467	-0.652	4.926	1.777
GROSS_HYPOXIA_VIA_ELK3_DN GROSS_HYPOXIA_VIA_ELK3_DN	-1.986	-1.030	-1.986	0.954	-1.030	-2.945	0.614	0.475	1.882	1.882	1.895
BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP	-2.288	-0.418	0.983	1.765	-0.291	-4.817	0.775	1.765	0.311	-1.055	0.443
FOSTER_KDM1A_TARGETS_DN FOSTER_KDM1A_TARGETS_DN	-2.760	0.559	1.843	0.341	-0.919	-3.779	2.092	0.341	2.356	-0.739	-0.580
BEIER_GLIOMA_STEM_CELL_DN BEIER_GLIOMA_STEM_CELL_DN	-1.855	-0.860	1.132	0.604	-0.566	-1.855	-2.737	2.673	0.846	-0.359	1.466
ALCALA_APOPTOSIS ALCALA_APOPTOSIS	-1.933	0.782	0.404	3.140	1.023	-3.610	0.782	-0.338	0.404	-0.505	-1.926
ONDER_CDH1_TARGETS_3_DN ONDER_CDH1_TARGETS_3_DN	-1.606	-1.606	-0.691	-0.691	-0.260	2.676	-0.260	-2.446	-0.260	1.411	2.686
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10	-1.999	0.997	0.997	1.636	-0.422	-2.903	-0.422	2.872	0.342	-1.393	-0.956
IKEDA_MIR30_TARGETS_UP IKEDA_MIR30_TARGETS_UP	-1.055	-0.792	-1.055	0.983	0.311	-3.714	2.076	3.986	0.311	-0.291	-1.049
MIKKELSEN_ES_LCP_WITH_H3K4ME3 MIKKELSEN_ES_LCP_WITH_H3K4ME3	1.687	-0.638	-3.193	-1.362	-0.350	0.985	-1.074	-1.706	0.628	0.482	4.062
PEART_HDAC_PROLIFERATION_CLUSTER_DN PEART_HDAC_PROLIFERATION_CLUSTER_DN	-2.035	0.712	2.806	1.259	-0.668	-2.945	0.712	0.712	-0.438	0.328	-2.028
JI_RESPONSE_TO_FSH_DN JI_RESPONSE_TO_FSH_DN	-0.893	-0.893	1.706	4.295	-0.556	-2.197	-0.893	1.706	-0.332	-0.893	-0.553
ROSS_AML_WITH_MLL_FUSIONS ROSS_AML_WITH_MLL_FUSIONS	-3.319	-0.865	0.724	0.353	-0.596	-3.319	-0.255	0.724	0.724	1.243	1.911
HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN	-1.364	-0.473	-1.868	-1.364	-0.313	-1.364	-0.691	0.289	1.082	2.034	4.772
GALE_APL_WITH_FLT3_MUTATED_UP GALE_APL_WITH_FLT3_MUTATED_UP	-1.606	-0.260	2.213	0.541	-0.691	-2.446	2.676	1.075	0.346	-1.064	-1.601
ZHAN_MULTIPLE_MYELOMA_SUBGROUPS ZHAN_MULTIPLE_MYELOMA_SUBGROUPS	-1.243	2.361	1.796	2.361	-0.320	-1.243	-0.320	-0.640	-0.320	-1.243	-1.240
YU_MYC_TARGETS_UP YU_MYC_TARGETS_UP	-1.782	-1.057	-0.354	2.353	-0.624	-1.782	0.254	1.423	2.896	-0.354	-1.053
FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP	-2.156	-0.535	0.476	5.050	0.720	-2.156	0.720	0.286	-0.865	-0.535	-0.532
BOYLAN_MULTIPLE_MYELOMA_C_D_UP BOYLAN_MULTIPLE_MYELOMA_C_D_UP	-0.751	0.710	2.789	1.325	0.301	-5.775	-1.252	0.414	0.301	0.301	-0.414
LINDGREN_BLADDER_CANCER_CLUSTER_1_UP LINDGREN_BLADDER_CANCER_CLUSTER_1_UP	-1.872	-1.872	1.960	0.716	1.137	-3.017	1.661	1.387	0.400	-0.848	-1.113
MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP	-0.813	-0.366	-0.366	-0.366	-0.486	-5.731	-1.027	0.722	2.295	1.507	1.519
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP	-2.809	-1.704	1.576	2.199	0.481	-2.194	0.344	1.875	0.645	-1.310	-0.377
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11	-1.006	0.249	2.429	2.071	0.249	-3.107	0.921	-0.360	0.707	-3.107	-0.517
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP	0.326	-0.427	-0.633	-1.771	-0.911	-0.633	-1.771	-0.278	-0.278	1.176	6.822
ZHU_CMV_24_HR_UP ZHU_CMV_24_HR_UP	-2.436	0.484	3.955	0.679	-0.278	-3.402	0.484	-0.278	0.679	-0.427	-0.906
BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2 BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2	-1.393	-0.422	4.988	1.297	0.342	-1.999	0.342	0.737	-0.647	-1.999	-0.643
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP	-1.783	-0.329	0.440	0.906	-1.211	-2.654	3.832	0.651	0.906	-0.329	-1.206
TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP	-1.739	-1.739	-0.888	0.339	0.339	-2.400	0.502	4.554	1.516	0.339	-0.409
FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN	-0.837	-0.837	1.818	1.818	-0.837	-1.328	1.818	1.412	-1.328	-0.301	-2.108
PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN	-2.031	0.546	1.137	2.929	0.814	-2.031	0.334	-0.472	0.334	-0.472	-2.026
GAVIN_FOXP3_TARGETS_CLUSTER_P3 GAVIN_FOXP3_TARGETS_CLUSTER_P3	0.364	0.364	-1.221	-0.767	-2.250	-3.260	0.268	-0.337	0.770	3.034	2.725
ISHIDA_E2F_TARGETS ISHIDA_E2F_TARGETS	-2.156	-0.535	2.690	0.286	-0.535	-2.156	0.720	1.017	1.761	-0.535	-1.357
GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP	0.662	-1.044	-1.288	-2.281	-0.660	-1.572	-0.836	0.309	1.177	1.853	4.419
SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE	-1.828	0.359	1.136	0.507	-1.029	-4.192	2.381	-0.373	1.702	-0.537	-0.248
LIU_VMYB_TARGETS_UP LIU_VMYB_TARGETS_UP	-2.043	0.990	-0.727	2.045	-0.727	-4.059	0.331	1.470	1.746	-0.727	-0.270
GOZGIT_ESR1_TARGETS_UP GOZGIT_ESR1_TARGETS_UP	0.421	-1.474	-0.921	-0.921	0.554	-1.173	-1.474	-0.292	-0.921	4.584	3.059
VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP	-0.860	-0.359	2.673	3.664	0.604	-1.855	-0.860	0.250	0.405	-1.271	-1.848
GAVIN_FOXP3_TARGETS_CLUSTER_P4 GAVIN_FOXP3_TARGETS_CLUSTER_P4	-0.537	0.359	-1.381	0.507	-1.381	-4.192	-0.537	0.507	1.136	2.760	1.143
TAKAO_RESPONSE_TO_UVB_RADIATION_DN TAKAO_RESPONSE_TO_UVB_RADIATION_DN	-3.032	-0.696	0.398	2.921	0.398	-3.032	1.507	1.224	-0.336	-0.696	-0.333
JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP	-1.571	-0.668	2.275	-0.247	-1.571	-2.405	-1.035	0.814	2.275	0.362	0.819
BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP	-1.188	1.666	0.595	0.330	-1.188	-2.365	0.330	-3.617	1.948	1.406	0.601
BILANGES_SERUM_RESPONSE_TRANSLATION BILANGES_SERUM_RESPONSE_TRANSLATION	-0.407	-0.407	2.010	5.381	-0.407	-0.407	-0.407	-1.409	-1.409	-0.407	-0.762
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	-1.016	-0.594	-0.594	0.283	-2.034	-3.093	-0.442	0.283	1.781	2.703	2.389
LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN	1.837	-0.756	-0.552	-1.013	0.333	0.816	-4.734	-0.552	-0.272	0.333	2.884
PLASARI_TGFB1_TARGETS_10HR_UP PLASARI_TGFB1_TARGETS_10HR_UP	1.738	0.386	-2.624	-0.844	-3.090	-0.844	-0.528	-0.408	0.926	1.104	3.140
CHOI_ATL_STAGE_PREDICTOR CHOI_ATL_STAGE_PREDICTOR	-1.090	-0.650	0.430	4.677	-0.373	-1.824	1.798	0.430	-0.373	-1.090	-1.086
GERY_CEBP_TARGETS GERY_CEBP_TARGETS	0.384	-0.461	-1.392	-0.831	-1.392	-2.218	-1.392	0.518	1.298	2.130	3.563
SMIRNOV_RESPONSE_TO_IR_6HR_DN SMIRNOV_RESPONSE_TO_IR_6HR_DN	-0.756	0.333	-0.552	-1.732	-1.013	-3.638	-0.272	2.157	2.870	1.032	0.471
DANG_REGULATED_BY_MYC_UP DANG_REGULATED_BY_MYC_UP	-0.910	-0.240	4.596	2.119	-0.240	-2.820	-0.390	-0.240	-0.910	-0.910	-0.387
BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS	-2.737	-0.566	1.458	1.132	0.846	-2.737	1.458	0.604	-0.359	0.250	-1.266
WIELAND_UP_BY_HBV_INFECTION WIELAND_UP_BY_HBV_INFECTION	-1.460	-0.280	-0.585	0.323	-1.918	-1.918	0.323	-1.460	2.244	2.244	2.255
CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP	-0.385	-1.051	-1.407	-0.771	-1.858	-1.051	0.492	-0.771	1.108	4.456	1.997
ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	0.617	-1.424	-2.101	-3.012	-0.926	0.485	-0.327	-0.327	0.768	2.343	2.971
MORI_PRE_BI_LYMPHOCYTE_DN MORI_PRE_BI_LYMPHOCYTE_DN	-0.369	-1.171	-1.643	-0.369	-0.559	-3.236	2.389	0.381	2.813	0.381	0.562
EPPERT_HSC_R EPPERT_HSC_R	-2.072	2.008	0.321	1.712	-0.282	-4.097	-0.282	-0.552	2.008	-0.282	-0.738
SMIRNOV_RESPONSE_TO_IR_6HR_UP SMIRNOV_RESPONSE_TO_IR_6HR_UP	-0.634	0.336	0.336	-0.813	-2.331	-4.004	1.507	1.752	1.076	1.752	-0.628
MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED	2.609	-0.885	-1.302	-0.374	0.388	1.416	-2.779	-1.891	-0.374	0.818	1.102
WINTER_HYPOXIA_UP WINTER_HYPOXIA_UP	-1.201	-0.624	1.653	0.456	-2.882	-2.882	1.080	-0.290	1.653	1.351	-0.429
KAYO_AGING_MUSCLE_DN KAYO_AGING_MUSCLE_DN	-3.227	-0.538	1.746	3.080	-0.273	-0.963	0.610	0.788	-0.538	-2.573	0.463
BURTON_ADIPOGENESIS_5 BURTON_ADIPOGENESIS_5	-1.099	1.695	1.695	1.163	0.291	-3.790	0.735	0.735	-0.312	-0.829	-2.340
GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP	-1.393	-0.961	-0.422	2.872	0.342	-2.903	1.297	1.297	0.737	-1.393	-0.419
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1	-0.647	0.519	-0.961	-1.999	-1.393	-1.999	-0.422	0.342	1.297	2.872	2.021
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP	0.479	1.094	0.479	-0.560	-1.997	-5.447	0.277	-0.714	1.508	1.293	0.922
RIZ_ERYTHROID_DIFFERENTIATION RIZ_ERYTHROID_DIFFERENTIATION	-1.771	0.484	3.955	1.477	-0.633	-2.436	0.909	-0.633	0.484	-1.280	-0.629
LAIHO_COLORECTAL_CANCER_SERRATED_DN LAIHO_COLORECTAL_CANCER_SERRATED_DN	-2.584	1.052	1.052	0.806	1.052	-2.584	-0.489	0.806	0.278	0.806	-2.575
BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN	-2.277	-0.782	1.810	2.992	-0.464	-3.291	0.754	1.118	0.355	-0.464	-0.776
LI_INDUCED_T_TO_NATURAL_KILLER_DN LI_INDUCED_T_TO_NATURAL_KILLER_DN	-0.940	0.745	0.933	1.635	-0.396	-4.522	-1.209	1.379	-1.535	0.933	0.586
WINZEN_DEGRADED_VIA_KHSRP WINZEN_DEGRADED_VIA_KHSRP	-0.521	-1.355	-2.365	-0.521	-0.733	0.249	-1.006	-0.360	0.524	2.813	4.136
MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3	3.240	-1.209	-1.535	-1.535	0.320	1.379	-1.535	-1.926	0.580	0.933	1.153
MEISSNER_NPC_HCP_WITH_H3K27ME3 MEISSNER_NPC_HCP_WITH_H3K27ME3	0.538	-1.198	-1.198	-1.198	1.277	5.290	-0.577	-1.198	-0.842	-0.577	1.001
MIKKELSEN_MCV6_ICP_WITH_H3K27ME3 MIKKELSEN_MCV6_ICP_WITH_H3K27ME3	0.824	-1.117	-0.775	-0.523	-0.775	2.501	-2.217	-2.217	0.412	1.387	1.733
ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE	1.546	-0.329	-1.783	-1.211	-1.783	-0.329	-1.211	-0.329	-0.329	2.349	2.819
OKUMURA_INFLAMMATORY_RESPONSE_LPS OKUMURA_INFLAMMATORY_RESPONSE_LPS	-2.662	1.025	-0.491	1.025	-1.529	-3.742	-0.278	1.025	0.691	1.912	0.557
MIKKELSEN_ES_ICP_WITH_H3K27ME3 MIKKELSEN_ES_ICP_WITH_H3K27ME3	1.928	-0.336	-1.024	-1.741	-1.024	1.477	0.269	-0.599	-1.741	0.269	2.440
SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_DN	0.762	-0.663	-0.663	-0.663	1.939	3.556	-0.663	-0.247	-0.663	-0.663	-0.661
BURTON_ADIPOGENESIS_PEAK_AT_2HR BURTON_ADIPOGENESIS_PEAK_AT_2HR	-0.702	0.389	-1.158	0.389	-1.907	-0.702	-1.907	-0.411	1.677	2.134	1.684
AMIT_EGF_RESPONSE_480_HELA AMIT_EGF_RESPONSE_480_HELA	-1.201	-0.957	0.630	0.374	-1.828	-3.228	-0.441	-0.328	1.870	2.748	1.390
WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN	-1.592	-0.279	1.385	0.472	-2.845	-2.845	1.109	0.324	2.029	0.651	-0.415
LAIHO_COLORECTAL_CANCER_SERRATED_UP LAIHO_COLORECTAL_CANCER_SERRATED_UP	-2.256	-1.034	-1.034	0.610	0.322	-2.878	2.116	0.610	2.820	0.452	-0.401
HOLLERN_EMT_BREAST_TUMOR_UP HOLLERN_EMT_BREAST_TUMOR_UP	-0.430	-0.767	-1.274	-0.767	-1.274	-2.007	-0.996	0.872	1.545	1.545	3.877
LINDSTEDT_DENDRITIC_CELL_MATURATION_C LINDSTEDT_DENDRITIC_CELL_MATURATION_C	-2.571	-0.301	0.301	0.301	-0.489	-2.571	0.301	0.478	-0.489	0.701	4.022
GAVIN_FOXP3_TARGETS_CLUSTER_T4 GAVIN_FOXP3_TARGETS_CLUSTER_T4	-2.994	0.575	0.771	0.575	-0.324	-4.026	0.279	-0.324	0.997	1.859	-0.321
TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP	-1.090	0.998	-0.650	-0.373	-1.824	-1.090	-0.650	-1.090	1.370	0.998	3.396
FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP	-1.990	-1.225	0.571	-0.256	-0.256	-1.990	0.571	1.180	3.588	-0.256	-0.752
SONG_TARGETS_OF_IE86_CMV_PROTEIN SONG_TARGETS_OF_IE86_CMV_PROTEIN	-1.466	2.015	2.973	0.416	-0.600	-2.280	0.416	0.910	-0.949	-0.600	-0.945
BASSO_CD40_SIGNALING_DN BASSO_CD40_SIGNALING_DN	-0.276	-0.276	-0.438	1.259	-2.035	-2.945	-0.668	-0.668	0.499	0.966	3.293
COLLER_MYC_TARGETS_UP COLLER_MYC_TARGETS_UP	-0.994	0.426	4.649	0.772	-0.462	-0.994	0.772	-0.994	-0.994	-0.462	-0.460
BILD_CTNNB1_ONCOGENIC_SIGNATURE BILD_CTNNB1_ONCOGENIC_SIGNATURE	-1.171	-1.171	0.772	1.997	0.381	-0.820	0.772	0.772	1.638	-3.236	-1.165
BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP	-0.405	1.639	-1.362	-0.533	-2.922	-1.362	-1.669	0.660	1.406	1.891	1.417
WHITFIELD_CELL_CYCLE_LITERATURE WHITFIELD_CELL_CYCLE_LITERATURE	-1.824	0.684	0.684	0.998	0.239	-1.824	-1.824	0.998	1.798	0.239	-1.086
ELVIDGE_HIF1A_TARGETS_UP ELVIDGE_HIF1A_TARGETS_UP	-2.820	-0.390	0.560	-0.390	0.560	-2.820	2.119	1.375	0.790	-0.390	-0.602
PARK_APL_PATHOGENESIS_DN PARK_APL_PATHOGENESIS_DN	-1.990	-0.451	0.571	-0.755	-0.256	-1.990	-0.755	-0.451	1.180	0.848	3.600
SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN	-0.614	-0.614	1.516	0.701	-1.253	-3.360	1.516	2.230	-0.266	-1.253	-0.264
CERVERA_SDHB_TARGETS_1_UP CERVERA_SDHB_TARGETS_1_UP	-0.496	0.254	-0.905	-1.186	-1.957	-0.905	-1.186	0.364	0.500	3.232	3.650
WEI_MIR34A_TARGETS WEI_MIR34A_TARGETS	-1.113	-0.371	0.759	2.187	-0.869	-3.977	-0.371	2.828	0.759	-0.371	-0.862
TONG_INTERACT_WITH_PTTG1 TONG_INTERACT_WITH_PTTG1	-2.363	0.587	1.151	2.339	-1.536	-2.363	0.379	0.845	-0.399	-0.235	-0.233
VERNELL_RETINOBLASTOMA_PATHWAY_UP VERNELL_RETINOBLASTOMA_PATHWAY_UP	-1.999	0.737	1.636	0.997	0.519	-2.903	0.737	1.297	-1.393	-0.647	-0.643
BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN	-0.278	-0.278	-1.249	-2.229	-1.249	-1.529	-0.491	0.326	0.849	3.075	3.094
MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP	-0.497	-0.497	0.524	-0.497	-0.497	-0.497	-0.497	-0.497	5.787	0.524	-0.496
PECE_MAMMARY_STEM_CELL_DN PECE_MAMMARY_STEM_CELL_DN	-0.490	-0.652	-0.258	2.872	-0.851	-3.940	0.964	2.538	-0.490	-0.851	-0.255
ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP	-3.483	-0.301	0.818	1.639	-1.669	-1.669	1.891	1.406	0.660	-0.877	-0.298
SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY	-1.367	0.754	1.130	2.092	0.453	-1.367	0.754	0.453	-0.733	-1.367	-1.364
AMIT_DELAYED_EARLY_GENES AMIT_DELAYED_EARLY_GENES	-0.746	0.304	-0.746	0.304	-0.746	-0.746	-0.746	-0.746	3.182	2.399	-0.297
RICKMAN_HEAD_AND_NECK_CANCER_A RICKMAN_HEAD_AND_NECK_CANCER_A	2.608	-0.280	-0.411	-2.500	-0.411	0.461	-1.460	-0.585	-1.460	0.461	3.429
BROWNE_HCMV_INFECTION_18HR_UP BROWNE_HCMV_INFECTION_18HR_UP	-2.922	-0.689	0.402	0.995	0.301	-2.440	0.660	2.160	1.891	0.402	-1.658
WENDT_COHESIN_TARGETS_UP WENDT_COHESIN_TARGETS_UP	-1.326	-0.702	-1.326	2.177	-0.363	-1.326	1.184	2.177	0.480	-0.363	-0.699
GEORGES_CELL_CYCLE_MIR192_TARGETS GEORGES_CELL_CYCLE_MIR192_TARGETS	-1.152	-0.489	2.037	0.478	-0.762	-2.571	2.037	1.640	0.301	-1.152	-0.758
LUI_THYROID_CANCER_PAX8_PPARG_DN LUI_THYROID_CANCER_PAX8_PPARG_DN	-1.907	-0.228	1.271	1.677	-0.702	-1.158	0.389	2.134	0.389	-1.907	-0.699
UEDA_PERIFERAL_CLOCK UEDA_PERIFERAL_CLOCK	-1.063	-0.385	0.423	1.035	-2.386	-3.419	-0.510	2.520	-0.285	1.456	0.861
TANG_SENESCENCE_TP53_TARGETS_DN TANG_SENESCENCE_TP53_TARGETS_DN	-0.977	-2.322	-0.622	0.877	-0.622	-1.501	0.397	1.957	2.895	0.397	-0.619
HOEBEKE_LYMPHOID_STEM_CELL_UP HOEBEKE_LYMPHOID_STEM_CELL_UP	0.412	0.412	1.542	2.204	-0.476	-2.994	-0.678	0.575	0.771	-0.476	-2.984
JACKSON_DNMT1_TARGETS_UP JACKSON_DNMT1_TARGETS_UP	-0.911	-1.280	-0.427	1.176	-1.280	-3.402	-0.278	0.909	0.679	1.812	1.183
BILD_SRC_ONCOGENIC_SIGNATURE BILD_SRC_ONCOGENIC_SIGNATURE	0.330	-1.093	3.099	1.739	-1.642	-1.642	0.330	-1.642	1.039	-0.274	-0.449
BROCKE_APOPTOSIS_REVERSED_BY_IL6 BROCKE_APOPTOSIS_REVERSED_BY_IL6	-0.851	-1.731	0.469	1.173	-0.652	-4.832	0.348	0.964	1.404	0.469	0.972
ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP	-1.362	-0.478	-0.834	0.482	-0.350	-2.117	-0.834	-1.074	1.963	0.985	4.062
FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP	0.376	-1.077	1.528	-1.477	-0.364	-3.693	-0.771	0.736	1.856	0.967	0.379
THILLAINADESAN_ZNF217_TARGETS_UP THILLAINADESAN_ZNF217_TARGETS_UP	-0.991	-0.574	0.783	1.129	0.783	-1.699	-0.318	3.082	0.285	-1.699	-0.987
BURTON_ADIPOGENESIS_6 BURTON_ADIPOGENESIS_6	-2.571	0.405	-0.389	1.559	-0.294	-4.170	1.343	0.962	-0.294	1.343	-0.640
BOYLAN_MULTIPLE_MYELOMA_D_DN BOYLAN_MULTIPLE_MYELOMA_D_DN	-0.412	-0.614	1.856	-0.888	-1.739	-3.360	-0.266	1.516	0.502	1.516	0.342
LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP	-1.925	-0.525	-1.062	-0.525	-1.062	-2.746	1.361	0.514	1.825	2.083	1.166
HECKER_IFNB1_TARGETS HECKER_IFNB1_TARGETS	-0.279	-1.176	-0.854	0.324	-0.279	-0.606	-0.418	-1.176	0.324	-0.606	7.509
FERNANDEZ_BOUND_BY_MYC FERNANDEZ_BOUND_BY_MYC	-1.529	-1.249	1.663	4.119	-1.529	-1.249	0.849	-0.491	0.429	0.691	-1.001
WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR	-1.858	0.410	1.059	0.540	-0.728	-4.121	1.511	1.511	1.059	-0.413	-0.932
ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN	-0.671	-0.341	0.509	2.878	-0.671	-1.284	1.719	0.836	-0.341	-1.284	-1.281
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN	-0.762	0.701	-1.712	0.301	-0.762	-0.762	-1.152	-1.712	1.640	1.640	2.484
YAGI_AML_FAB_MARKERS YAGI_AML_FAB_MARKERS	-1.860	-0.672	0.766	1.104	-1.045	-3.623	0.386	-0.528	0.496	1.104	2.831
VANTVEER_BREAST_CANCER_ESR1_UP VANTVEER_BREAST_CANCER_ESR1_UP	-1.781	-0.275	0.329	1.597	-0.886	-3.293	1.351	-1.133	2.459	-0.275	0.588
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7	-2.144	0.445	4.069	1.466	-0.314	-1.517	0.878	-0.488	-0.732	-1.064	-0.485
BAKKER_FOXO3_TARGETS_UP BAKKER_FOXO3_TARGETS_UP	-0.348	-0.348	-0.348	0.944	-0.578	-2.239	0.664	-2.239	3.053	0.944	-0.575
KIM_ALL_DISORDERS_DURATION_CORR_DN KIM_ALL_DISORDERS_DURATION_CORR_DN	-1.731	1.404	1.404	1.656	-0.851	-1.731	1.404	0.777	-0.490	-0.490	-2.625
UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN	-0.234	-0.234	-1.492	-1.492	-0.828	-0.828	-0.453	-0.453	0.646	2.977	2.397
NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN	1.366	-0.981	-2.547	-0.691	0.289	-0.313	-0.981	-0.473	-0.691	1.082	4.248
DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2 DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2	-0.598	-0.598	3.102	3.925	-0.430	-1.408	-1.077	0.755	-0.810	-1.077	-0.593
MCLACHLAN_DENTAL_CARIES_DN MCLACHLAN_DENTAL_CARIES_DN	1.812	-0.427	-0.633	-0.911	-0.427	-0.278	-3.402	0.679	-0.427	3.467	-0.424
WU_APOPTOSIS_BY_CDKN1A_VIA_TP53 WU_APOPTOSIS_BY_CDKN1A_VIA_TP53	-0.893	-0.893	1.706	-0.332	-1.397	-2.197	0.691	0.980	2.616	0.272	-0.888
FARMER_BREAST_CANCER_CLUSTER_2 FARMER_BREAST_CANCER_CLUSTER_2	-0.733	-0.733	0.453	0.453	-0.733	-1.367	0.453	1.130	4.000	-0.733	-1.364
BHAT_ESR1_TARGETS_VIA_AKT1_DN BHAT_ESR1_TARGETS_VIA_AKT1_DN	0.326	1.176	-1.280	-1.771	-1.280	-2.436	1.812	-0.633	0.679	1.477	0.915
HAHTOLA_SEZARY_SYNDROM_UP HAHTOLA_SEZARY_SYNDROM_UP	-1.768	-0.984	0.259	2.477	-2.331	-1.768	0.540	0.540	1.779	-0.348	0.952
SEKI_INFLAMMATORY_RESPONSE_LPS_UP SEKI_INFLAMMATORY_RESPONSE_LPS_UP	-0.577	-1.675	-0.842	-1.198	-0.842	-0.383	-0.577	-0.577	1.277	3.681	2.345
VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN	1.763	-0.352	-2.831	-1.819	-0.656	0.255	0.361	-1.819	0.820	1.763	1.503
GENTLES_LEUKEMIC_STEM_CELL_DN GENTLES_LEUKEMIC_STEM_CELL_DN	-0.787	-0.787	-0.787	-0.324	0.279	-0.787	-0.324	0.609	-0.787	0.609	4.791
KAMIKUBO_MYELOID_CEBPA_NETWORK KAMIKUBO_MYELOID_CEBPA_NETWORK	-0.320	-0.640	-0.640	-0.320	-0.320	-1.243	-1.243	-0.640	0.283	1.796	4.449
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN	-0.578	-0.921	-0.921	-0.578	-1.431	-0.921	0.435	-0.578	0.944	0.664	5.496
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP	-0.831	-0.625	-0.461	0.384	-2.218	-2.766	-0.331	0.273	2.452	1.298	2.143
FAELT_B_CLL_WITH_VH3_21_DN FAELT_B_CLL_WITH_VH3_21_DN	-2.031	-0.782	0.814	-0.271	-0.472	-2.031	1.512	1.137	1.137	0.814	-1.255
ROSS_LEUKEMIA_WITH_MLL_FUSIONS ROSS_LEUKEMIA_WITH_MLL_FUSIONS	-1.225	1.243	0.353	0.965	-1.225	-3.319	-0.397	-0.596	0.520	2.693	-0.253
STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	-1.373	-0.351	1.610	-0.264	0.442	-4.403	0.442	2.636	0.692	-0.264	-1.120
BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN	-1.741	-0.336	1.928	-0.336	0.269	-1.741	0.269	1.928	0.749	0.269	-1.736
MCBRYAN_PUBERTAL_BREAST_4_5WK_DN MCBRYAN_PUBERTAL_BREAST_4_5WK_DN	-2.760	0.559	2.092	1.393	-0.458	-3.236	0.341	1.610	-0.458	0.341	-0.732
PHONG_TNF_TARGETS_UP PHONG_TNF_TARGETS_UP	-0.315	-0.508	-0.786	-0.508	-2.613	-1.181	0.459	-0.786	1.244	2.878	1.600
ROSS_ACUTE_MYELOID_LEUKEMIA_CBF ROSS_ACUTE_MYELOID_LEUKEMIA_CBF	-0.427	0.679	-1.280	1.477	-0.633	-3.402	-0.911	-0.633	1.176	0.679	1.821
MORI_MATURE_B_LYMPHOCYTE_DN MORI_MATURE_B_LYMPHOCYTE_DN	-2.180	0.620	0.428	1.769	-2.180	-2.180	0.850	1.119	0.620	0.428	-0.749
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT	1.899	-0.522	-2.658	-0.522	-1.053	-0.751	-0.351	-1.053	1.264	0.390	3.092
BURTON_ADIPOGENESIS_PEAK_AT_16HR BURTON_ADIPOGENESIS_PEAK_AT_16HR	-1.024	0.749	4.939	0.749	0.269	-1.741	-0.336	-0.336	-1.024	-0.599	-0.596
NAKAJIMA_EOSINOPHIL NAKAJIMA_EOSINOPHIL	0.398	-0.222	-1.036	-1.036	-1.036	-0.491	0.398	0.398	0.398	-1.036	4.474
VALK_AML_CLUSTER_13 VALK_AML_CLUSTER_13	-0.341	0.509	-0.671	-0.671	-1.284	-1.284	0.509	-1.284	0.264	2.878	1.725
BURTON_ADIPOGENESIS_9 BURTON_ADIPOGENESIS_9	-0.672	-1.836	0.301	-0.958	-1.836	-1.336	-0.301	0.636	1.112	2.081	2.480
HOLLERN_EMT_BREAST_TUMOR_DN HOLLERN_EMT_BREAST_TUMOR_DN	2.540	-0.661	-1.164	-0.661	-1.164	0.262	-1.164	-1.928	0.376	2.201	1.898
ELVIDGE_HYPOXIA_UP ELVIDGE_HYPOXIA_UP	-0.676	-2.001	-0.395	0.835	-1.646	-2.892	0.309	1.015	2.193	0.675	1.442
HUPER_BREAST_BASAL_VS_LUMINAL_DN HUPER_BREAST_BASAL_VS_LUMINAL_DN	0.362	-0.668	-2.405	-0.668	-0.416	-0.416	-0.668	-0.247	-0.668	2.747	3.269
SESTO_RESPONSE_TO_UV_C0 SESTO_RESPONSE_TO_UV_C0	-2.671	-1.595	0.928	1.715	0.392	-1.595	1.426	0.928	0.928	-0.479	-1.207
LI_AMPLIFIED_IN_LUNG_CANCER LI_AMPLIFIED_IN_LUNG_CANCER	-1.044	-2.281	0.662	5.604	-0.660	-0.836	0.662	-1.044	0.309	0.409	-0.290
RICKMAN_HEAD_AND_NECK_CANCER_F RICKMAN_HEAD_AND_NECK_CANCER_F	0.233	-1.501	-1.501	-0.977	0.612	1.551	-0.382	-1.501	-0.622	1.190	2.906
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN	1.900	-0.399	-1.536	-1.006	-0.645	-1.006	-0.645	-0.645	0.587	-0.235	4.507
MIKKELSEN_MEF_LCP_WITH_H3K27ME3 MIKKELSEN_MEF_LCP_WITH_H3K27ME3	2.366	0.966	-2.035	-2.035	0.499	0.966	-1.424	-0.668	-0.668	-0.276	1.266
SASSON_RESPONSE_TO_GONADOTROPHINS_DN SASSON_RESPONSE_TO_GONADOTROPHINS_DN	-1.005	-0.711	-0.489	-0.711	-0.711	-2.584	-0.711	3.203	1.052	1.644	0.812
AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53 AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53	-0.465	0.280	-0.889	1.191	-1.190	-4.484	-0.323	1.458	0.952	0.405	0.959
ROZANOV_MMP14_TARGETS_SUBSET ROZANOV_MMP14_TARGETS_SUBSET	1.577	-0.733	-1.367	-1.367	-0.385	-0.385	-1.367	-0.385	1.577	0.754	1.583
LUI_THYROID_CANCER_CLUSTER_3 LUI_THYROID_CANCER_CLUSTER_3	-1.160	0.324	0.978	2.564	-0.580	-1.160	-0.580	1.962	-0.280	-1.160	-0.577
WONG_ENDMETRIUM_CANCER_DN WONG_ENDMETRIUM_CANCER_DN	0.381	-0.369	-1.643	-3.236	-0.369	0.772	-0.559	-0.369	1.024	0.243	3.282
HOELZEL_NF1_TARGETS_UP HOELZEL_NF1_TARGETS_UP	1.074	0.403	-0.996	-0.996	-2.485	-0.767	-1.608	-0.430	1.074	1.813	2.428
DALESSIO_TSA_RESPONSE DALESSIO_TSA_RESPONSE	-0.491	-1.036	-0.491	-1.036	-0.222	1.149	-0.491	-0.491	-1.036	3.655	1.153
MCDOWELL_ACUTE_LUNG_INJURY_UP MCDOWELL_ACUTE_LUNG_INJURY_UP	-0.729	-0.431	-0.729	-1.191	-0.729	-1.191	-1.191	0.597	0.883	1.620	3.700
LIN_NPAS4_TARGETS_UP LIN_NPAS4_TARGETS_UP	-1.063	-0.845	1.035	1.695	-0.510	-4.073	-0.385	1.695	1.236	0.423	-0.838
PHONG_TNF_RESPONSE_VIA_P38_PARTIAL PHONG_TNF_RESPONSE_VIA_P38_PARTIAL	-0.752	-0.752	-0.441	0.630	-2.224	-2.224	-0.581	0.276	1.379	3.422	1.172
BILBAN_B_CLL_LPL_DN BILBAN_B_CLL_LPL_DN	-0.599	-1.024	1.477	0.269	-1.741	-1.741	-1.024	0.749	0.476	0.749	1.935
SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2 SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2	0.920	-0.702	-1.158	-0.228	-0.411	-0.411	-1.907	-0.411	-0.702	0.920	4.446
ONDER_CDH1_SIGNALING_VIA_CTNNB1 ONDER_CDH1_SIGNALING_VIA_CTNNB1	2.081	-0.458	-1.836	-0.672	-0.958	-0.958	-0.958	-0.958	0.636	2.468	1.735
SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP	1.277	0.367	1.277	2.335	-0.842	-2.326	0.367	0.748	-0.842	-1.675	-1.192
PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN	-0.556	-0.420	-0.420	-1.162	-1.446	-0.722	-0.923	-0.420	0.292	2.212	5.113
KYNG_DNA_DAMAGE_DN KYNG_DNA_DAMAGE_DN	-1.269	-1.551	2.145	-0.382	-1.027	-3.193	1.882	0.676	0.538	0.419	0.840
HOEBEKE_LYMPHOID_STEM_CELL_DN HOEBEKE_LYMPHOID_STEM_CELL_DN	-1.053	-1.448	0.557	0.256	-0.522	-3.652	1.899	0.995	-0.351	0.759	1.001
BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE	-0.451	-0.755	0.571	2.001	-1.225	-1.990	2.001	0.571	0.848	-0.755	-1.221
CAFFAREL_RESPONSE_TO_THC_24HR_5_UP CAFFAREL_RESPONSE_TO_THC_24HR_5_UP	-0.733	-0.385	2.092	2.669	0.754	-1.367	-1.367	-0.385	0.453	-0.733	-0.730
ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP	-0.652	0.657	-0.442	-0.652	-1.308	-2.473	-0.652	-0.652	1.768	2.946	1.150
ONDER_CDH1_TARGETS_1_UP ONDER_CDH1_TARGETS_1_UP	-0.959	-1.231	-0.407	-0.292	-0.407	-3.689	-0.407	0.727	1.880	2.495	0.734
HOELZEL_NF1_TARGETS_DN HOELZEL_NF1_TARGETS_DN	0.959	-1.077	-0.810	0.301	-0.301	-1.077	-2.319	-0.430	-0.598	2.037	3.519
YAGI_AML_SURVIVAL YAGI_AML_SURVIVAL	-0.377	-0.524	1.244	1.244	-0.264	-4.020	-0.377	0.627	-0.943	2.410	-0.937
RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	-1.153	0.568	0.725	-0.904	0.433	-4.949	0.903	-0.528	0.433	1.832	0.573
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP	-1.160	-0.580	0.324	0.607	-1.160	-1.160	-0.280	1.432	1.432	1.432	-1.157
WANG_METHYLATED_IN_BREAST_CANCER WANG_METHYLATED_IN_BREAST_CANCER	-1.450	-0.219	0.403	-1.450	-0.796	-0.430	-0.796	-0.430	1.030	0.680	3.751
JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-1.927	-0.390	-0.606	-0.606	-0.910	-0.606	-0.390	-0.606	0.560	1.728	4.612
HOWLIN_PUBERTAL_MAMMARY_GLAND HOWLIN_PUBERTAL_MAMMARY_GLAND	-1.302	-0.374	-1.891	0.581	-0.374	1.096	-0.586	-0.885	-0.885	0.818	4.136
LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN	-3.093	0.522	0.283	1.781	-0.442	-3.093	1.051	1.516	0.283	-0.320	-0.317
BURTON_ADIPOGENESIS_8 BURTON_ADIPOGENESIS_8	-1.675	-0.577	0.367	0.994	-1.198	-1.675	-1.198	0.748	3.681	0.538	0.370
SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN	-1.367	-0.385	0.754	-0.385	1.577	-1.367	2.092	0.754	0.231	-1.367	-0.730
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP	-1.792	-0.473	0.264	2.411	-1.104	-3.475	0.840	0.264	1.271	0.660	0.376
STEIN_ESRRA_TARGETS_DN STEIN_ESRRA_TARGETS_DN	-0.438	-0.617	1.249	2.892	0.432	-2.568	0.593	1.249	-0.617	-1.143	-1.506
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP	-1.682	-0.465	0.369	-0.817	-0.465	-3.159	1.222	0.495	3.320	0.814	-0.336
JIANG_VHL_TARGETS JIANG_VHL_TARGETS	-1.901	-0.711	1.644	1.052	-1.005	-1.901	0.595	1.988	1.052	-0.489	-0.999
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP	-0.486	-2.276	-0.486	-0.486	0.255	-1.819	-0.352	0.255	0.255	1.763	4.275
KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN	1.023	-0.505	-1.420	-1.029	-0.731	1.297	0.267	-1.420	-1.420	1.023	3.154
KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN	-1.659	-2.831	0.751	1.094	0.277	-1.114	-0.327	2.842	1.508	-0.560	-0.554
LINDSTEDT_DENDRITIC_CELL_MATURATION_D LINDSTEDT_DENDRITIC_CELL_MATURATION_D	-0.489	-1.712	-0.301	-0.489	-0.762	-2.571	0.970	0.301	0.701	0.701	2.961
KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN	-0.288	-1.012	0.688	0.314	-0.689	-2.986	0.481	1.911	2.309	-0.454	-1.007
CHICAS_RB1_TARGETS_LOW_SERUM CHICAS_RB1_TARGETS_LOW_SERUM	-1.434	1.080	1.080	1.080	0.476	-0.790	1.945	-0.569	-1.074	0.334	-3.209
FURUKAWA_DUSP6_TARGETS_PCI35_DN FURUKAWA_DUSP6_TARGETS_PCI35_DN	-1.012	-0.288	0.688	-0.288	0.314	-1.012	-1.012	1.223	4.236	-0.454	-2.064
GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP	1.859	-0.324	-1.709	-1.709	0.279	0.575	-1.278	-0.678	-0.940	1.255	2.590
DER_IFN_ALPHA_RESPONSE_UP DER_IFN_ALPHA_RESPONSE_UP	-2.144	1.153	-0.732	2.200	-0.314	-2.144	0.878	-0.488	1.153	0.445	-1.059
RIGGI_EWING_SARCOMA_PROGENITOR_DN RIGGI_EWING_SARCOMA_PROGENITOR_DN	0.507	-1.528	-1.528	-1.837	-0.829	0.396	-1.260	0.944	1.765	0.781	2.572
ELVIDGE_HYPOXIA_BY_DMOG_UP ELVIDGE_HYPOXIA_BY_DMOG_UP	-0.641	-2.247	-0.641	0.840	-1.104	-2.247	-0.473	1.522	1.044	1.044	1.808
PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP	-0.348	1.274	-2.239	-1.431	-0.348	-1.431	0.258	0.435	3.053	0.258	0.438
MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT	1.744	-0.462	-0.994	-0.994	-0.994	-0.462	-0.994	0.772	-0.204	2.357	0.428
ROSS_AML_WITH_PML_RARA_FUSION ROSS_AML_WITH_PML_RARA_FUSION	-2.400	0.502	-1.253	0.339	-0.888	-0.888	-0.888	0.339	1.516	0.701	3.084
ROSS_AML_WITH_AML1_ETO_FUSION ROSS_AML_WITH_AML1_ETO_FUSION	-0.820	1.024	-1.171	0.381	-1.643	-2.290	-0.369	0.243	0.772	0.558	3.282
COATES_MACROPHAGE_M1_VS_M2_UP COATES_MACROPHAGE_M1_VS_M2_UP	-0.711	0.278	0.806	-1.901	-0.489	-3.568	0.595	1.988	0.595	0.595	0.423
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN	-0.600	2.015	0.245	0.245	-1.466	-1.466	0.910	0.910	1.232	-0.365	-2.274
HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN	0.274	0.651	0.274	-1.211	-1.211	-1.211	-1.783	-0.329	0.274	1.205	3.845
HARRIS_BRAIN_CANCER_PROGENITORS HARRIS_BRAIN_CANCER_PROGENITORS	0.453	0.254	0.254	-1.782	-1.057	0.254	-1.782	-0.624	0.254	1.861	2.362
GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN	-1.707	-0.596	-0.397	0.353	-0.865	-2.363	-0.255	-0.255	1.902	3.136	0.524
KHETCHOUMIAN_TRIM24_TARGETS_UP KHETCHOUMIAN_TRIM24_TARGETS_UP	-0.411	-0.702	-0.702	-0.228	-0.411	-1.907	-0.702	-0.702	0.625	1.677	3.803
KIM_WT1_TARGETS_8HR_UP KIM_WT1_TARGETS_8HR_UP	-1.261	0.345	0.457	-0.356	-0.798	-4.742	2.046	0.345	1.097	0.457	0.745
HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP	-0.580	-0.280	0.978	4.769	-0.580	-1.160	-0.580	0.324	-0.280	-0.280	-1.157
WILCOX_RESPONSE_TO_PROGESTERONE_UP WILCOX_RESPONSE_TO_PROGESTERONE_UP	-1.255	-0.775	0.500	0.377	-1.566	-1.566	2.542	1.430	1.947	-0.329	-1.246
MEBARKI_HCC_PROGENITOR_WNT_DN MEBARKI_HCC_PROGENITOR_WNT_DN	1.138	0.889	-2.807	-0.589	-0.589	-0.268	-0.589	-0.833	-1.151	1.138	2.858
BASSO_CD40_SIGNALING_UP BASSO_CD40_SIGNALING_UP	-0.771	-0.553	-0.553	-0.385	-0.771	-3.183	0.492	-0.553	2.334	2.334	0.879
GENTILE_UV_RESPONSE_CLUSTER_D4 GENTILE_UV_RESPONSE_CLUSTER_D4	-2.239	0.258	0.435	0.664	0.258	-2.239	1.652	0.664	1.274	-0.578	-0.916
LIAN_LIPA_TARGETS_6M LIAN_LIPA_TARGETS_6M	0.353	-0.397	-0.865	-2.363	-0.255	-0.255	-1.225	-0.255	0.353	0.353	5.214
GAJATE_RESPONSE_TO_TRABECTEDIN_UP GAJATE_RESPONSE_TO_TRABECTEDIN_UP	-1.271	0.405	-0.359	-0.359	-1.855	-0.860	-0.359	-0.359	0.250	0.604	5.416
LEE_LIVER_CANCER_ACOX1_DN LEE_LIVER_CANCER_ACOX1_DN	-0.344	-0.344	-1.241	-1.819	-1.819	0.876	-0.546	0.262	0.262	2.740	1.885
FIGUEROA_AML_METHYLATION_CLUSTER_6_DN FIGUEROA_AML_METHYLATION_CLUSTER_6_DN	-0.860	-0.860	-0.860	0.359	-0.860	1.332	-0.477	-0.250	-1.533	1.332	2.885
BURTON_ADIPOGENESIS_PEAK_AT_8HR BURTON_ADIPOGENESIS_PEAK_AT_8HR	-1.575	-1.575	2.222	1.721	-0.893	-0.893	0.584	-0.500	0.339	0.584	-0.265
BYSTROEM_CORRELATED_WITH_IL5_DN BYSTROEM_CORRELATED_WITH_IL5_DN	-1.571	-0.247	0.814	1.456	-0.416	-2.405	0.564	1.844	0.362	-0.247	-1.566
MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS	-0.477	0.614	-1.533	-0.860	-0.250	-1.533	1.788	-0.860	-0.250	2.304	0.617
OHGUCHI_LIVER_HNF4A_TARGETS_DN OHGUCHI_LIVER_HNF4A_TARGETS_DN	1.507	-1.926	-0.813	-1.578	0.336	0.445	-1.281	-1.281	1.076	1.076	2.310
LUI_TARGETS_OF_PAX8_PPARG_FUSION LUI_TARGETS_OF_PAX8_PPARG_FUSION	-1.409	0.216	2.010	1.079	-0.765	-1.409	0.216	2.010	0.216	-0.765	-0.762
TOOKER_GEMCITABINE_RESISTANCE_DN TOOKER_GEMCITABINE_RESISTANCE_DN	-1.558	-1.209	2.452	-0.366	-0.366	-3.157	0.828	1.272	0.828	0.353	-0.362
ZHAN_V2_LATE_DIFFERENTIATION_GENES ZHAN_V2_LATE_DIFFERENTIATION_GENES	-1.865	-0.676	0.654	-0.392	0.409	-1.865	0.958	2.722	-0.392	0.654	-0.673
CHEBOTAEV_GR_TARGETS_DN CHEBOTAEV_GR_TARGETS_DN	2.286	-0.566	-1.661	-1.661	-0.566	-1.003	-0.292	-0.566	0.311	0.749	3.379
MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD	0.997	0.737	-2.903	-0.647	-0.422	-0.961	-0.422	-0.647	-0.422	0.997	2.884
GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN	-0.810	-0.411	1.905	-0.411	0.461	-4.317	1.593	-0.280	0.461	-0.585	0.465
BROWNE_HCMV_INFECTION_24HR_UP BROWNE_HCMV_INFECTION_24HR_UP	-1.406	-0.267	1.377	0.597	-0.503	-3.259	-0.667	1.150	2.498	0.338	-0.862
DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP	-1.397	0.272	-0.893	-0.556	-0.332	-2.197	-0.332	-0.332	1.319	1.319	2.625
MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3	2.668	-0.744	-1.635	-1.277	-0.282	0.967	-2.072	-0.744	0.321	1.440	0.975
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN	-1.909	-0.436	-0.759	-0.320	-0.975	-2.852	0.659	1.979	1.016	1.457	0.834
ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP	-0.642	0.441	1.942	1.052	0.301	-3.943	0.301	1.052	-0.447	-1.227	-0.298
QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR	0.326	-0.427	-0.427	0.909	-1.771	-3.402	-0.278	0.484	2.578	0.484	0.329
BENPORATH_NOS_TARGETS BENPORATH_NOS_TARGETS	-0.621	-0.363	2.209	0.706	-1.508	-3.710	-0.363	0.335	1.045	1.457	-0.615
LIANG_SILENCED_BY_METHYLATION_UP LIANG_SILENCED_BY_METHYLATION_UP	0.231	0.231	-0.733	-1.367	-0.385	0.453	-0.385	-0.733	-1.367	1.577	3.315
KENNY_CTNNB1_TARGETS_UP KENNY_CTNNB1_TARGETS_UP	-0.492	-1.294	0.317	3.398	-2.073	-1.294	-0.285	0.317	0.317	1.095	0.319
CHIBA_RESPONSE_TO_TSA_UP CHIBA_RESPONSE_TO_TSA_UP	-1.294	-0.492	-1.294	-0.810	-0.810	-0.285	0.317	-0.492	1.877	0.317	4.004
RODRIGUES_DCC_TARGETS_DN RODRIGUES_DCC_TARGETS_DN	-0.333	0.272	0.388	0.530	-0.469	-4.983	0.891	1.111	0.530	0.891	-1.135
CROMER_TUMORIGENESIS_DN CROMER_TUMORIGENESIS_DN	-0.782	-0.782	-2.031	-0.472	0.334	1.137	-0.271	-1.259	0.334	0.546	3.503
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP	1.565	3.079	-0.522	-1.053	-1.053	-2.658	0.557	-0.751	0.256	0.557	0.259
MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN	-2.446	-0.260	0.346	0.541	-0.691	-1.606	0.541	1.411	2.213	0.346	-1.059
VALK_AML_WITH_EVI1 VALK_AML_WITH_EVI1	0.726	0.726	-1.036	-1.036	-0.491	-1.036	-1.036	-0.222	2.916	0.398	0.399
ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN	-1.064	0.878	-0.732	-1.064	-2.144	-1.517	0.878	0.878	2.200	0.878	0.291
BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP	-1.160	-0.580	-0.580	-0.580	0.607	-0.280	-1.160	0.324	-0.580	3.971	0.982
SMID_BREAST_CANCER_ERBB2_UP SMID_BREAST_CANCER_ERBB2_UP	0.809	-0.447	0.377	-0.993	0.377	0.809	-1.566	-1.255	-2.369	2.869	1.211
GESERICK_TERT_TARGETS_DN GESERICK_TERT_TARGETS_DN	-0.378	0.527	-0.870	0.527	-0.870	-0.870	-0.870	-0.870	0.527	2.036	1.440
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN	2.511	1.005	0.292	-1.446	-0.923	-1.162	-1.779	-0.310	-0.722	0.395	2.526
PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN	-0.652	-0.360	1.930	1.404	-0.851	-3.940	-0.258	0.777	1.173	-0.360	-0.845
EPPERT_LSC_R EPPERT_LSC_R	-1.024	0.476	1.083	1.083	1.083	-1.741	0.269	1.083	-0.336	-1.024	-1.736
MIKKELSEN_ES_HCP_WITH_H3K27ME3 MIKKELSEN_ES_HCP_WITH_H3K27ME3	0.285	0.501	-0.991	-0.318	-0.318	2.514	-1.699	-0.574	-0.991	-0.574	2.522
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE	-1.739	-0.266	1.516	0.502	0.502	-3.360	1.856	-0.266	0.339	-0.614	-0.264
BENPORATH_ES_CORE_NINE_CORRELATED BENPORATH_ES_CORE_NINE_CORRELATED	0.249	0.524	1.438	1.740	0.371	-3.107	0.371	0.707	-0.733	-0.360	-2.356
WESTON_VEGFA_TARGETS_6HR WESTON_VEGFA_TARGETS_6HR	1.512	0.546	-2.031	-2.031	-0.472	0.546	-1.259	-0.271	0.546	0.546	1.142
MORI_SMALL_PRE_BII_LYMPHOCYTE_DN MORI_SMALL_PRE_BII_LYMPHOCYTE_DN	-1.580	0.598	0.824	0.824	1.087	-2.217	0.598	-0.775	0.412	-2.217	1.093
LIAN_LIPA_TARGETS_3M LIAN_LIPA_TARGETS_3M	0.274	-0.527	-0.527	-1.783	0.274	-0.329	-1.211	-0.329	-0.329	0.440	5.637
MODY_HIPPOCAMPUS_PRENATAL MODY_HIPPOCAMPUS_PRENATAL	-0.373	-0.373	1.370	3.385	-0.650	-1.824	0.998	-1.090	-0.373	-0.373	-0.647
ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP	-1.741	-0.336	0.476	-1.024	0.476	-1.741	1.083	1.477	1.083	0.476	-1.020
LEE_NEURAL_CREST_STEM_CELL_UP LEE_NEURAL_CREST_STEM_CELL_UP	1.351	-0.515	-1.429	-0.886	-0.886	-0.381	-0.886	-1.429	0.445	3.132	1.876
GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN	1.024	-0.461	-1.252	-1.680	-0.918	-0.659	-0.313	1.024	-0.918	3.922	0.598
HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN	0.265	-0.775	1.724	-1.117	-2.217	-1.580	0.412	0.265	-0.341	0.824	2.512
KIM_WT1_TARGETS_12HR_UP KIM_WT1_TARGETS_12HR_UP	-0.261	-0.621	-0.261	0.345	-2.304	-3.323	-0.356	1.097	1.781	0.457	1.545
GREENBAUM_E2A_TARGETS_UP GREENBAUM_E2A_TARGETS_UP	-1.367	0.231	-0.733	-0.385	0.231	-1.367	0.231	0.754	4.000	0.453	-0.730
SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP	0.304	-0.746	-0.298	0.655	-0.746	-0.746	-0.746	-0.298	-0.746	3.182	1.132
MOOTHA_TCA MOOTHA_TCA	-0.663	-0.663	2.696	1.292	0.362	-0.663	0.762	-0.663	-0.247	-0.663	-0.661
WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP	-0.911	-0.911	1.356	0.490	0.217	-0.911	1.356	-0.911	1.356	-0.911	0.218
DELPUECH_FOXO3_TARGETS_UP DELPUECH_FOXO3_TARGETS_UP	-0.344	-0.835	-0.344	-0.546	-1.819	-1.819	1.502	-0.835	1.502	1.502	1.174
ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR	-0.199	-0.199	-0.580	-0.580	4.008	-0.580	-0.580	-0.580	-0.580	0.434	0.894
WORSCHECH_TUMOR_REJECTION_UP WORSCHECH_TUMOR_REJECTION_UP	-0.301	0.301	-0.762	0.701	-0.489	0.701	-1.152	-2.571	-0.489	0.478	3.474
JIANG_AGING_HYPOTHALAMUS_UP JIANG_AGING_HYPOTHALAMUS_UP	-0.782	0.334	1.938	-0.271	-0.271	-2.031	0.546	1.512	0.546	-0.472	-2.026
CROONQUIST_NRAS_SIGNALING_UP CROONQUIST_NRAS_SIGNALING_UP	-0.549	0.527	-0.549	-1.658	-0.958	-0.549	-0.549	-0.300	0.302	4.494	0.823
LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP	-0.580	-0.580	1.488	-0.580	-0.580	-0.580	-0.580	0.892	2.211	0.434	-0.578
MAYBURD_RESPONSE_TO_L663536_DN MAYBURD_RESPONSE_TO_L663536_DN	-1.466	-0.365	1.232	0.910	0.416	-2.280	0.637	1.601	0.416	-0.600	-1.461
KORKOLA_SEMINOMA_UP KORKOLA_SEMINOMA_UP	-1.090	0.684	-0.373	0.684	-1.824	-1.824	0.684	0.239	0.998	1.798	-0.647
RAMALHO_STEMNESS_DN RAMALHO_STEMNESS_DN	-1.064	1.153	-1.064	0.288	0.288	-3.070	-0.732	0.642	0.288	0.642	2.210
DIRMEIER_LMP1_RESPONSE_EARLY DIRMEIER_LMP1_RESPONSE_EARLY	-2.571	-0.489	-0.489	0.478	-0.762	-1.712	0.301	0.301	0.970	1.640	1.648
HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP	0.328	0.328	-0.276	-0.986	-0.668	-2.945	-0.438	-0.668	0.712	1.259	2.818
DIRMEIER_LMP1_RESPONSE_LATE_UP DIRMEIER_LMP1_RESPONSE_LATE_UP	-1.501	0.877	1.190	0.233	-0.382	-2.322	1.551	0.397	-1.501	-0.382	0.881
NEMETH_INFLAMMATORY_RESPONSE_LPS_UP NEMETH_INFLAMMATORY_RESPONSE_LPS_UP	-1.868	0.615	-0.313	0.615	-0.691	-3.527	0.435	0.831	-0.313	0.831	1.374
HU_ANGIOGENESIS_DN HU_ANGIOGENESIS_DN	-1.533	-0.250	1.332	2.304	0.614	-0.860	0.614	0.359	-0.477	-0.860	-1.529
CHOW_RASSF1_TARGETS_DN CHOW_RASSF1_TARGETS_DN	-1.243	-0.320	0.539	-0.320	-0.640	-1.243	-0.320	4.438	0.539	0.283	-0.638
MIKKELSEN_MEF_LCP_WITH_H3K4ME3 MIKKELSEN_MEF_LCP_WITH_H3K4ME3	0.420	0.563	-1.023	-1.023	-1.322	-1.322	-0.581	-1.023	0.923	1.935	2.950
SWEET_KRAS_ONCOGENIC_SIGNATURE SWEET_KRAS_ONCOGENIC_SIGNATURE	-1.053	-1.053	0.256	0.557	0.557	-2.658	-1.053	1.899	-0.351	0.390	2.274
SUNG_METASTASIS_STROMA_UP SUNG_METASTASIS_STROMA_UP	-1.214	-0.334	-0.668	0.542	-1.595	-2.071	-0.668	0.721	2.739	1.426	0.727
ZHOU_TNF_SIGNALING_4HR ZHOU_TNF_SIGNALING_4HR	-0.837	-0.837	0.301	0.498	0.301	-2.114	1.055	2.767	0.750	-1.328	-0.510
LIM_MAMMARY_LUMINAL_MATURE_UP LIM_MAMMARY_LUMINAL_MATURE_UP	-0.703	-0.703	-1.649	-0.508	-1.261	-0.703	-0.508	0.251	3.023	1.109	2.296
CHEOK_RESPONSE_TO_HD_MTX_DN CHEOK_RESPONSE_TO_HD_MTX_DN	-0.911	0.217	0.217	1.356	-0.406	-0.911	-0.406	2.594	0.873	-0.911	-0.909
SMIRNOV_RESPONSE_TO_IR_2HR_UP SMIRNOV_RESPONSE_TO_IR_2HR_UP	-0.893	-1.397	0.272	0.691	-1.397	-1.397	-0.332	0.455	1.319	3.135	-0.330
LY_AGING_OLD_DN LY_AGING_OLD_DN	-1.501	-0.977	1.551	0.612	0.397	-1.501	0.612	2.405	0.233	-0.382	-1.496
CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN	-0.678	0.771	0.279	-1.278	-2.264	-1.709	-0.476	0.575	2.577	0.997	0.776
DURAND_STROMA_NS_UP DURAND_STROMA_NS_UP	-1.261	-1.556	0.457	-1.010	-0.356	-1.556	-0.798	0.738	1.097	2.951	1.316
CERVERA_SDHB_TARGETS_2 CERVERA_SDHB_TARGETS_2	0.452	-1.034	0.322	-1.760	-1.034	-0.774	-0.281	-0.567	-0.281	1.246	4.521
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP	-1.077	-0.241	-1.077	-0.520	-0.520	0.684	0.371	-1.077	-0.241	0.684	3.516
KANG_GLIS3_TARGETS KANG_GLIS3_TARGETS	-0.234	0.984	-0.453	-0.828	3.619	-1.492	-0.453	-0.828	-0.828	0.984	-0.233
DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP	0.541	-1.064	-0.691	-0.260	-1.606	-0.691	-1.606	1.075	0.541	0.541	3.189
LUI_THYROID_CANCER_CLUSTER_1 LUI_THYROID_CANCER_CLUSTER_1	-1.362	0.720	-0.316	0.476	0.720	-2.156	-0.865	-0.865	0.720	2.690	-0.314
TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN	0.539	0.283	-1.243	-0.640	-0.640	0.539	-1.243	-1.243	0.880	0.539	2.368
BROWNE_HCMV_INFECTION_2HR_UP BROWNE_HCMV_INFECTION_2HR_UP	0.302	0.527	-1.658	0.302	-0.549	-0.300	-0.549	-0.549	-1.658	2.069	2.076
BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP	-0.344	-1.241	0.262	-0.344	-1.819	-1.819	-0.344	2.289	1.876	0.876	0.264
CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN	0.564	0.440	-0.993	-1.508	-0.479	0.335	-1.508	-1.230	-0.363	2.209	3.134
MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS	-0.704	0.332	1.206	1.821	-0.704	1.206	-0.704	-0.704	-0.704	0.332	-0.702
LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE	-0.472	0.814	-0.472	0.334	-2.031	-0.782	-0.782	-1.259	1.137	0.814	2.419
TSAI_RESPONSE_TO_IONIZING_RADIATION TSAI_RESPONSE_TO_IONIZING_RADIATION	-1.858	0.691	-0.939	-0.413	-1.497	-1.497	-0.301	0.301	1.059	2.344	1.781
DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN	1.455	-0.572	-2.770	-0.258	-0.812	-1.127	-0.258	-0.812	1.168	2.119	0.698
CHOW_RASSF1_TARGETS_UP CHOW_RASSF1_TARGETS_UP	-0.520	-0.520	2.792	1.088	0.371	-1.077	0.684	0.371	-1.077	-0.520	-1.074
WANG_TARGETS_OF_MLL_CBP_FUSION_DN WANG_TARGETS_OF_MLL_CBP_FUSION_DN	-1.124	0.226	1.736	2.204	0.654	-1.865	0.654	-0.676	-0.392	-1.124	-0.390
CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP	-0.283	-0.283	-0.283	-0.525	-1.616	-1.616	-0.283	-0.283	0.555	3.931	0.558
HONMA_DOCETAXEL_RESISTANCE HONMA_DOCETAXEL_RESISTANCE	-1.450	-1.450	0.680	2.478	0.680	-0.796	1.030	-0.430	0.403	-0.430	-0.793
CHUANG_OXIDATIVE_STRESS_RESPONSE_UP CHUANG_OXIDATIVE_STRESS_RESPONSE_UP	-1.160	-0.580	-1.160	0.607	-0.280	-0.280	0.607	-1.160	-0.280	3.235	0.609
VANHARANTA_UTERINE_FIBROID_DN VANHARANTA_UTERINE_FIBROID_DN	-1.302	0.818	-0.885	-1.302	-0.586	-1.302	-0.586	0.238	1.096	2.609	1.423
WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC	0.490	0.217	-0.911	-0.406	-0.911	0.490	-0.406	-0.911	-0.911	1.356	2.601
MIKKELSEN_MCV6_LCP_WITH_H3K27ME3 MIKKELSEN_MCV6_LCP_WITH_H3K27ME3	0.371	-0.241	-1.077	-0.520	0.371	2.792	-1.077	-1.077	-0.241	-0.520	1.583
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6	-0.341	-0.341	-1.117	-0.523	-1.117	-1.117	-1.117	0.265	3.408	2.096	0.603
SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2 SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2	-1.010	-0.356	-0.356	-1.010	-0.356	-3.323	0.457	0.345	2.951	1.534	0.462
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN	-1.501	1.957	0.397	0.397	0.397	-2.322	0.233	0.877	0.877	-0.382	-1.496
KIM_GLIS2_TARGETS_UP KIM_GLIS2_TARGETS_UP	-0.672	-0.458	-0.458	-0.301	-0.301	-1.336	-1.336	-0.958	0.856	1.112	4.326
SAGIV_CD24_TARGETS_DN SAGIV_CD24_TARGETS_DN	-0.392	-1.124	-1.124	0.226	-0.392	-0.392	-0.676	-0.676	-0.392	3.288	2.732
ENGELMANN_CANCER_PROGENITORS_DN ENGELMANN_CANCER_PROGENITORS_DN	-0.252	0.357	-0.626	-1.363	-0.252	0.357	-1.963	-0.935	-0.406	2.065	2.951
WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN	1.423	-1.782	0.254	-1.057	-1.057	2.353	-0.624	-0.624	-0.354	0.453	1.044
KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN	-1.865	0.409	0.958	3.898	-0.392	-1.124	-0.676	0.226	0.226	-0.676	0.227
AMIT_EGF_RESPONSE_40_HELA AMIT_EGF_RESPONSE_40_HELA	-0.599	0.269	0.269	-1.741	-1.741	-1.024	0.269	0.476	0.749	2.432	0.752
LANDIS_ERBB2_BREAST_TUMORS_324_UP LANDIS_ERBB2_BREAST_TUMORS_324_UP	-1.520	-0.310	-0.743	0.399	-0.743	-3.426	0.399	2.013	1.250	0.845	0.682
DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP	0.707	1.759	-1.105	-1.105	0.428	0.557	-2.091	-1.707	-0.678	1.278	1.520
IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM	-0.994	-0.994	0.772	0.772	-0.462	-0.994	0.772	2.357	-0.204	-0.994	-0.203
BROWNE_HCMV_INFECTION_14HR_UP BROWNE_HCMV_INFECTION_14HR_UP	-2.012	-0.260	0.756	1.591	-0.260	-2.976	1.591	0.463	0.934	-0.636	-0.816
ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN	-1.948	-0.431	0.597	0.883	-0.431	-1.948	1.225	1.225	0.883	-0.729	-0.429
CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP	-1.403	-0.718	0.284	-0.319	-1.403	-2.076	-0.558	0.785	2.096	2.096	0.965
VANTVEER_BREAST_CANCER_METASTASIS_DN VANTVEER_BREAST_CANCER_METASTASIS_DN	-1.595	-0.668	0.928	3.130	-1.214	-2.071	0.270	0.392	0.928	0.542	-0.475
STEIN_ESR1_TARGETS STEIN_ESR1_TARGETS	-3.444	0.467	1.144	0.467	-1.803	-0.442	0.657	-0.652	0.883	0.883	0.316
COLDREN_GEFITINIB_RESISTANCE_UP COLDREN_GEFITINIB_RESISTANCE_UP	-1.005	0.419	2.363	1.052	0.278	-2.584	-1.005	1.644	-0.489	-0.711	-0.323
LY_AGING_MIDDLE_DN LY_AGING_MIDDLE_DN	-0.663	-0.663	-0.247	-0.663	-0.247	-0.663	-0.247	3.556	0.762	0.762	-0.661
SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN	-0.652	-0.490	-1.093	-0.490	-0.360	-1.093	-0.360	-1.731	1.656	1.404	3.242
QI_HYPOXIA QI_HYPOXIA	-0.849	-0.849	-0.641	-0.473	-0.641	-2.798	0.372	3.111	1.271	0.504	0.847
LEI_HOXC8_TARGETS_DN LEI_HOXC8_TARGETS_DN	-0.704	-0.704	-0.704	-0.704	-0.704	-0.272	-0.272	0.332	1.821	2.541	0.333
RODWELL_AGING_KIDNEY_DN RODWELL_AGING_KIDNEY_DN	1.103	-0.697	-0.392	0.433	-0.697	-1.807	0.903	2.744	0.319	0.433	-2.716
PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP	-1.144	0.253	0.578	0.798	0.396	-3.194	0.253	2.444	0.578	-0.541	-0.793
HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP	-0.828	-0.351	0.256	2.866	-0.351	-0.828	0.991	0.991	-0.828	-0.351	-0.826
RASHI_RESPONSE_TO_IONIZING_RADIATION_2 RASHI_RESPONSE_TO_IONIZING_RADIATION_2	-0.727	-0.388	-0.388	-0.538	-0.963	-2.573	-0.538	-0.273	1.470	3.080	1.226
WATANABE_COLON_CANCER_MSI_VS_MSS_DN WATANABE_COLON_CANCER_MSI_VS_MSS_DN	2.546	-0.390	-1.332	-2.820	0.372	0.372	0.790	-0.910	-0.240	0.790	-0.238
CROONQUIST_STROMAL_STIMULATION_UP CROONQUIST_STROMAL_STIMULATION_UP	-0.382	0.397	-1.501	-0.622	-2.322	0.233	-0.622	0.233	0.877	1.190	2.415
NAKAJIMA_MAST_CELL NAKAJIMA_MAST_CELL	-0.702	-1.158	-0.411	0.920	-0.411	-0.411	-1.907	-0.411	-0.228	1.677	2.649
NELSON_RESPONSE_TO_ANDROGEN_UP NELSON_RESPONSE_TO_ANDROGEN_UP	-1.308	-1.308	0.883	-0.934	-0.442	-1.308	-0.652	0.313	2.946	0.657	1.447
PRAMOONJAGO_SOX4_TARGETS_UP PRAMOONJAGO_SOX4_TARGETS_UP	-0.893	-1.397	-0.332	0.980	-0.332	-2.197	-0.893	0.691	1.706	0.691	0.985
HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS	0.253	-0.541	-0.355	-0.797	-1.612	-0.355	-2.253	1.055	0.396	2.875	1.061
GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN	-0.456	-0.456	-0.456	0.187	-0.456	-0.456	0.187	-0.456	1.148	-0.456	3.768
ZHAN_MULTIPLE_MYELOMA_SPIKED ZHAN_MULTIPLE_MYELOMA_SPIKED	0.772	1.213	-0.994	-0.994	-0.462	-0.462	-0.462	-0.994	-0.462	0.772	2.363
BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP	-0.535	-0.535	0.476	0.286	-1.362	-1.362	-0.316	-0.535	4.401	1.017	-0.532
AMIT_SERUM_RESPONSE_120_MCF10A AMIT_SERUM_RESPONSE_120_MCF10A	-0.835	0.422	-0.835	-0.344	-1.819	-1.819	-0.546	1.168	1.876	0.876	1.174
STEARMAN_TUMOR_FIELD_EFFECT_UP STEARMAN_TUMOR_FIELD_EFFECT_UP	-0.860	-0.477	-1.533	-0.250	-0.477	-0.860	-0.477	-0.477	2.304	1.332	1.795
SESTO_RESPONSE_TO_UV_C6 SESTO_RESPONSE_TO_UV_C6	-1.616	0.320	2.144	0.555	-0.525	-1.616	-0.925	0.555	0.320	-0.525	1.231
ODONNELL_TFRC_TARGETS_DN ODONNELL_TFRC_TARGETS_DN	-2.515	-0.594	0.283	0.676	-0.784	-1.632	1.051	1.272	2.375	0.391	-0.778
ONDER_CDH1_TARGETS_1_DN ONDER_CDH1_TARGETS_1_DN	-1.976	-0.662	2.520	3.158	-1.321	-0.285	-0.510	-0.662	0.318	-0.385	0.322
VALK_AML_WITH_CEBPA VALK_AML_WITH_CEBPA	-0.477	-0.860	1.788	-1.533	-0.860	-1.533	0.359	0.614	0.614	0.359	1.338
MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN	-0.787	0.279	-0.787	0.279	0.279	-0.787	2.269	1.613	0.279	-0.787	-0.785
CROMER_METASTASIS_UP CROMER_METASTASIS_UP	-1.486	0.301	0.301	-1.038	-0.471	-2.107	0.664	3.630	0.664	0.301	-0.298
BORLAK_LIVER_CANCER_EGF_UP BORLAK_LIVER_CANCER_EGF_UP	-0.921	-0.921	-0.348	0.435	-1.431	-0.921	-0.348	-0.921	1.652	1.652	2.084
GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP	-1.308	0.313	-1.308	0.883	-0.652	-2.473	-0.652	0.883	1.144	1.439	0.888
GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP	-0.647	-0.264	-0.422	1.297	-0.422	-1.999	-0.961	-1.393	0.519	1.297	2.435
SENGUPTA_EBNA1_ANTICORRELATED SENGUPTA_EBNA1_ANTICORRELATED	-0.301	0.840	-1.424	-0.301	-0.707	-3.765	0.301	1.025	2.247	0.406	0.410
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN	-1.367	-0.733	0.453	0.231	-0.385	-1.367	0.754	-0.733	3.306	0.231	0.455
HOWLIN_CITED1_TARGETS_1_DN HOWLIN_CITED1_TARGETS_1_DN	-0.477	-0.477	-0.477	-0.860	-0.477	-1.533	0.614	3.503	0.940	0.614	-0.857
LEE_AGING_CEREBELLUM_UP LEE_AGING_CEREBELLUM_UP	-1.280	-0.427	0.484	0.326	-0.427	-0.427	0.679	-1.280	-0.427	-0.911	5.032
MELLMAN_TUT1_TARGETS_UP MELLMAN_TUT1_TARGETS_UP	-0.828	-0.351	0.256	1.521	0.256	-0.828	2.866	0.256	-0.828	-0.828	-0.350
BURTON_ADIPOGENESIS_7 BURTON_ADIPOGENESIS_7	0.521	-1.294	0.521	-0.285	-1.294	-2.073	-0.810	0.317	1.095	1.461	1.101
BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP	0.346	0.346	-0.691	-1.606	-0.434	-2.446	-0.434	1.075	0.346	0.784	2.222
CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP	-1.294	1.095	1.877	1.095	-0.492	-2.073	0.521	-0.285	0.317	-1.294	-0.283
RADAEVA_RESPONSE_TO_IFNA1_UP RADAEVA_RESPONSE_TO_IFNA1_UP	-1.948	0.597	1.620	0.370	0.597	-1.948	-0.729	-0.729	-0.242	0.597	0.887
RAHMAN_TP53_TARGETS_PHOSPHORYLATED RAHMAN_TP53_TARGETS_PHOSPHORYLATED	-0.828	-0.351	2.148	0.991	0.256	-0.828	1.521	-0.828	-0.351	-0.351	-0.826
LEE_LIVER_CANCER_E2F1_UP LEE_LIVER_CANCER_E2F1_UP	-0.786	-0.786	-0.786	-0.508	0.459	-0.508	-1.748	-0.315	1.244	0.459	3.933
SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL	-0.835	-1.241	0.627	0.262	-0.835	-2.696	1.876	0.422	1.168	0.627	0.264
ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP	-0.733	-1.367	-0.385	0.231	0.231	-0.733	-0.733	0.453	2.669	-0.733	2.098
PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP	0.256	0.566	0.566	2.148	-0.828	-0.828	0.256	0.991	-0.828	-0.828	-0.826
WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN	-0.250	-1.533	-0.860	-1.533	-0.250	0.614	-0.860	0.614	0.614	0.614	2.311
SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE	-0.885	-0.885	-0.586	0.581	-0.586	-2.779	1.096	0.238	2.174	0.581	0.585
TOOKER_GEMCITABINE_RESISTANCE_UP TOOKER_GEMCITABINE_RESISTANCE_UP	-0.865	0.520	-0.255	1.902	-0.255	-1.707	-0.397	0.724	1.902	-0.397	-2.355
DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP	-1.549	0.620	0.850	-0.506	-1.549	-2.180	0.620	-0.506	0.620	1.769	0.856
VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP	-0.223	-0.621	0.396	-0.621	-0.621	-0.621	3.770	0.823	-0.223	-0.223	-0.620
YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0	0.328	-0.276	-0.276	-2.035	-1.424	-1.424	-0.438	0.712	0.499	2.806	0.972
HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP	-1.181	-0.508	-1.181	-0.315	0.288	-1.748	-0.786	0.675	0.938	2.878	0.943
WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP	0.873	-0.911	0.217	-0.406	-0.911	-0.911	0.217	0.873	2.594	0.217	-0.909
LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP	-1.699	-0.991	-0.574	0.783	-0.318	-1.699	1.129	0.285	0.783	0.285	1.540
PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP	-1.117	-1.580	0.412	4.438	0.598	-1.117	0.412	-0.523	0.412	-0.523	-0.338
MARTIN_INTERACT_WITH_HDAC MARTIN_INTERACT_WITH_HDAC	-1.658	1.176	0.527	1.594	0.527	-1.658	0.527	-0.549	0.527	-0.549	-0.954
BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP	-1.508	1.328	1.595	0.376	-1.928	-1.928	-0.661	0.515	1.328	0.515	-0.340
IKEDA_MIR133_TARGETS_UP IKEDA_MIR133_TARGETS_UP	-0.373	0.684	-0.373	1.798	-0.650	-1.090	1.370	1.370	-0.650	-1.824	-0.647
LIM_MAMMARY_LUMINAL_PROGENITOR_UP LIM_MAMMARY_LUMINAL_PROGENITOR_UP	1.112	0.564	-1.571	-0.668	-1.571	0.564	-0.668	-1.035	-0.416	1.844	1.463
KUNINGER_IGF1_VS_PDGFB_TARGETS_UP KUNINGER_IGF1_VS_PDGFB_TARGETS_UP	0.937	-0.266	-0.412	-1.739	0.339	0.937	-3.360	-0.266	-0.266	0.701	1.216
MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP	0.497	1.832	-0.909	0.382	-1.714	-2.982	0.382	0.632	-0.426	-0.319	1.845
KANG_DOXORUBICIN_RESISTANCE_DN KANG_DOXORUBICIN_RESISTANCE_DN	-0.787	-0.324	-0.787	0.609	-0.787	-0.787	2.269	0.609	0.609	0.609	-0.785
ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN	0.281	3.392	0.914	0.281	-1.457	-1.872	-0.848	-0.848	0.281	1.137	-0.452
SAFFORD_T_LYMPHOCYTE_ANERGY SAFFORD_T_LYMPHOCYTE_ANERGY	-1.077	-0.364	0.246	-0.538	-1.077	-1.477	-0.771	-0.364	0.967	1.856	3.032
ZHU_CMV_ALL_UP ZHU_CMV_ALL_UP	-2.009	0.576	3.240	0.976	-0.451	-2.009	0.290	0.290	0.419	-0.312	-0.863
GAL_LEUKEMIC_STEM_CELL_UP GAL_LEUKEMIC_STEM_CELL_UP	-0.436	-0.595	0.407	0.902	-1.713	-1.346	0.548	0.291	3.260	-1.713	0.718
LUI_THYROID_CANCER_PAX8_PPARG_UP LUI_THYROID_CANCER_PAX8_PPARG_UP	-1.907	1.271	0.920	0.625	-0.228	-1.907	0.389	-1.158	-0.228	0.920	-0.226
MENSE_HYPOXIA_UP MENSE_HYPOXIA_UP	-1.355	-0.521	0.371	-0.360	-0.733	-3.107	0.524	2.429	0.921	0.371	0.712
FURUKAWA_DUSP6_TARGETS_PCI35_UP FURUKAWA_DUSP6_TARGETS_PCI35_UP	-0.471	0.906	-2.107	-0.710	-0.301	-0.301	-1.486	0.906	-0.471	0.463	3.151
BROWNE_HCMV_INFECTION_30MIN_UP BROWNE_HCMV_INFECTION_30MIN_UP	0.272	0.455	-2.197	2.139	-0.893	1.319	-0.556	-0.893	0.455	-0.893	0.695
GOLDRATH_IMMUNE_MEMORY GOLDRATH_IMMUNE_MEMORY	-0.810	0.651	-0.329	0.651	-1.211	-2.654	-0.810	0.440	1.928	0.440	0.911
MORI_IMMATURE_B_LYMPHOCYTE_UP MORI_IMMATURE_B_LYMPHOCYTE_UP	-2.073	-0.492	-0.810	0.521	-0.492	-1.294	1.877	0.317	1.877	-0.285	0.525
KORKOLA_CORRELATED_WITH_POU5F1 KORKOLA_CORRELATED_WITH_POU5F1	-0.702	-1.326	1.184	-0.702	-1.326	-0.702	0.480	-0.363	1.647	1.184	0.482
BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP	-0.490	-1.093	-1.093	-0.360	-0.258	0.348	-1.384	-1.384	1.173	2.538	1.942
SHEPARD_BMYB_TARGETS SHEPARD_BMYB_TARGETS	-0.523	-2.217	-0.775	-1.117	-0.341	0.265	0.265	1.387	3.408	-0.341	0.415
RUIZ_TNC_TARGETS_UP RUIZ_TNC_TARGETS_UP	-0.260	-0.823	-0.823	0.347	-1.318	-2.455	-0.260	0.347	2.428	0.463	2.143
AFFAR_YY1_TARGETS_UP AFFAR_YY1_TARGETS_UP	0.875	-0.712	-1.929	0.270	-0.712	-0.889	-1.335	-0.437	0.583	2.151	2.438
HASLINGER_B_CLL_WITH_11Q23_DELETION HASLINGER_B_CLL_WITH_11Q23_DELETION	-0.434	-0.953	1.835	1.835	-0.434	-0.953	-0.434	-0.434	0.821	0.457	-0.950
DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP	0.274	0.274	-0.810	0.440	-2.654	-0.527	-1.211	1.205	0.906	-0.329	1.937
LIANG_SILENCED_BY_METHYLATION_2 LIANG_SILENCED_BY_METHYLATION_2	-0.260	-1.064	-1.064	-0.260	-1.064	1.411	-1.064	-0.691	-0.260	1.411	2.686
DAUER_STAT3_TARGETS_UP DAUER_STAT3_TARGETS_UP	-0.472	-2.031	0.546	0.334	-0.782	-0.472	-0.782	-0.472	0.334	3.492	0.818
SABATES_COLORECTAL_ADENOMA_UP SABATES_COLORECTAL_ADENOMA_UP	0.536	-0.767	-0.430	-0.996	-0.311	1.074	-1.608	-1.608	-0.430	2.746	1.556
BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN	1.086	-0.483	-0.343	-1.164	-1.164	0.262	-0.885	-1.164	-0.483	1.595	3.301
SENESE_HDAC2_TARGETS_DN SENESE_HDAC2_TARGETS_DN	0.504	-0.849	-0.849	-1.792	-1.104	1.522	-0.849	-0.849	1.044	1.796	1.280
MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP	0.731	0.563	-0.581	0.301	-1.023	-1.322	-1.687	-0.778	-0.424	1.647	2.950
HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN	-0.828	0.256	2.866	0.991	0.256	-0.828	0.566	-0.351	-0.828	-0.828	-0.350
HASINA_NOL7_TARGETS_UP HASINA_NOL7_TARGETS_UP	-0.538	-0.538	-0.538	-0.538	-0.176	-0.538	-0.538	0.967	3.261	0.476	-0.176
MOOTHA_FFA_OXYDATION MOOTHA_FFA_OXYDATION	-0.953	1.282	0.199	1.282	0.457	-0.953	1.282	-0.434	0.199	-0.953	-0.950
KIM_MYCN_AMPLIFICATION_TARGETS_DN KIM_MYCN_AMPLIFICATION_TARGETS_DN	-0.634	-0.451	0.290	-0.634	-0.869	-3.372	-0.312	1.491	1.220	1.491	0.581
MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP	-0.351	0.566	-0.828	-0.828	-0.351	0.991	-0.351	-0.828	-0.828	0.991	2.154
MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN	-0.704	0.332	-0.704	-0.272	-0.272	-0.704	-0.272	-0.704	3.361	1.206	-0.271
NGO_MALIGNANT_GLIOMA_1P_LOH NGO_MALIGNANT_GLIOMA_1P_LOH	-0.621	-0.223	-0.621	3.770	0.396	-0.621	-0.223	-0.621	-0.621	0.396	0.398
XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP	-0.621	-0.223	0.396	3.770	-0.621	-0.621	0.396	-0.223	-0.621	0.396	-0.620
MISSIAGLIA_REGULATED_BY_METHYLATION_UP MISSIAGLIA_REGULATED_BY_METHYLATION_UP	-1.277	-0.744	-0.400	-0.400	-0.552	-1.277	-0.983	0.321	3.415	1.712	0.775
YAMAZAKI_TCEB3_TARGETS_UP YAMAZAKI_TCEB3_TARGETS_UP	-0.347	0.468	-1.534	-0.782	0.260	-3.291	-0.464	1.330	1.118	0.754	1.340
CHEN_PDGF_TARGETS CHEN_PDGF_TARGETS	-0.746	-0.746	-0.298	-0.298	-0.746	-0.746	0.304	0.304	1.128	3.182	-0.297
SASSON_RESPONSE_TO_FORSKOLIN_UP SASSON_RESPONSE_TO_FORSKOLIN_UP	-1.966	-0.351	-0.351	-0.351	-0.522	-1.966	0.759	3.079	-0.351	0.390	1.001
CHANDRAN_METASTASIS_TOP50_DN CHANDRAN_METASTASIS_TOP50_DN	-0.650	-0.650	-1.090	-0.650	-0.373	-1.824	0.239	2.277	0.998	0.684	1.003
LEE_NEURAL_CREST_STEM_CELL_DN LEE_NEURAL_CREST_STEM_CELL_DN	1.328	0.262	-0.885	-0.661	-1.164	-0.661	-0.343	-1.928	2.540	0.262	1.605
DELLA_RESPONSE_TO_TSA_AND_BUTYRATE DELLA_RESPONSE_TO_TSA_AND_BUTYRATE	-0.828	-0.828	-0.828	0.991	-0.828	-0.828	0.256	0.991	0.256	0.991	0.994
SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER	1.264	-0.351	-1.053	-1.053	-1.448	0.557	-0.522	-1.448	0.390	1.264	2.274
CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP	-0.510	-0.510	-0.694	0.486	-1.558	-1.558	-0.366	-0.366	0.353	3.577	1.541
GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB	-2.145	0.612	2.224	0.469	-0.258	-2.145	0.777	-0.851	0.612	0.777	-0.845
YAMAZAKI_TCEB3_TARGETS_DN YAMAZAKI_TCEB3_TARGETS_DN	-0.351	-0.919	1.193	-0.586	-0.351	-3.236	1.193	0.442	2.092	0.442	-0.911
JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN	0.332	-0.704	-0.704	-0.704	-0.272	-0.272	-0.272	-0.704	-0.272	1.821	2.547
DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS	-0.870	0.236	-0.870	-0.378	-0.870	2.725	0.527	-0.378	-0.378	-0.378	1.440
LEE_METASTASIS_AND_RNA_PROCESSING_UP LEE_METASTASIS_AND_RNA_PROCESSING_UP	-0.663	0.362	0.762	2.696	-0.247	-0.663	0.762	-0.663	-0.247	-0.663	-0.661
PIONTEK_PKD1_TARGETS_DN PIONTEK_PKD1_TARGETS_DN	0.706	-0.704	0.332	0.706	2.541	-0.704	-0.704	-0.704	0.332	-0.704	-0.271
INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP	-0.580	0.892	2.211	-0.580	-0.580	-0.580	0.434	0.892	-0.199	-0.580	-0.578
MANN_RESPONSE_TO_AMIFOSTINE_DN MANN_RESPONSE_TO_AMIFOSTINE_DN	-0.373	-0.373	4.432	0.240	-0.373	-0.373	0.240	-0.373	0.240	-0.373	-0.372
